<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://genmapp.org/GPML/2010a" Name="Signaling by EGFR" Organism="Homo sapiens" Data-Source="Reactome - http://www.reactome.org" Version="release 35" Author="Jassal, B, Castagnoli, L">
  <Comment Source="WikiPathways-description">The epidermal growth factor receptor (EGFR) is one member of the ErbB family of transmembrane glycoprotein tyrosine receptor kinases (RTK). Binding of EGFR to its ligands leads to autophosphorylation of tyrosine residues on the receptor and subsequent activation of signal transduction pathways that are involved in regulating cellular proliferation, differentiation, and survival. Ligand binding with EGFR results in receptor homo- or heterodimerization at the cell surface. Trans-autophosphorylation of the EGFR tyrosine kinase domains occurs and the phosphorylated tyrosine kinase residues serve as binding sites for the recruitment of signal transducers and activators of intracellular substrates, such as Ras, which then stimulate an intracellular signal transduction cascade.</Comment>
  <Comment Source="WikiPathways-category">Cellular Process</Comment>
  <BiopaxRef>lit_188592</BiopaxRef>
  <BiopaxRef>lit_188596</BiopaxRef>
  <BiopaxRef>lit_188660</BiopaxRef>
  <BiopaxRef>lit_188661</BiopaxRef>
  <DataNode GraphId="n2_REACTOME_179888" TextLabel="pro-EGF precursor&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="98.5" CenterY="109.0" Width="117.0" Height="22.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="P01133"/>
  </DataNode>
  <DataNode GraphId="n3_REACTOME_179856" TextLabel="Phosphatidylinositol-&#10;4,5-bisphosphate&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="1961.0" CenterY="167.0" Width="136.0" Height="44.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="18348"/>
  </DataNode>
  <DataNode GraphId="n4_REACTOME_179845" TextLabel="EGF:EGFR dimer&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="644.0" CenterY="96.0" Width="102.0" Height="22.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_9820"/>
  </DataNode>
  <DataNode GraphId="n5_REACTOME_182939" TextLabel="EGF:Phospho-EGFR &#10;(Y1045) dimer:CBL:&#10;Phospho-Sprouty &#10;ubiquitinated&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="3214.0" CenterY="471.0" Width="124.0" Height="64.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_12687"/>
  </DataNode>
  <DataNode GraphId="n8_REACTOME_180500" TextLabel="PAG1&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="1639.0" CenterY="352.0" Width="40.0" Height="22.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="Q9NWQ8"/>
  </DataNode>
  <DataNode GraphId="n9_REACTOME_180269" TextLabel="SHP2-GRB2:Phospho &#10;GAB1-EGF-Phospho-&#10;EGFR dimer&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="1687.0" CenterY="579.0" Width="134.0" Height="64.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_12771"/>
  </DataNode>
  <DataNode GraphId="n12_REACTOME_109788" TextLabel="RAS:RAF&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="206.0" CenterY="614.0" Width="56.0" Height="22.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_3036"/>
  </DataNode>
  <DataNode GraphId="n14_REACTOME_74789" TextLabel="PI3K-p85&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="1073.5" CenterY="692.0" Width="65.0" Height="22.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="P27986"/>
  </DataNode>
  <DataNode GraphId="n15_REACTOME_182956" TextLabel="CBL:Cool/Pix:&#10;CDC42-GTP&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="1904.5" CenterY="762.0" Width="85.0" Height="36.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_13219"/>
  </DataNode>
  <DataNode GraphId="n16_REACTOME_180522" TextLabel="Paxillin:CSK:Src &#10;complex&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="1793.5" CenterY="359.0" Width="99.0" Height="36.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_12813"/>
  </DataNode>
  <DataNode GraphId="n19_REACTOME_179837" TextLabel="EGFR&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="226.0" CenterY="147.0" Width="38.0" Height="22.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="P00533"/>
  </DataNode>
  <DataNode GraphId="n20_REACTOME_179847" TextLabel="EGF:EGFR&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="472.0" CenterY="96.0" Width="64.0" Height="22.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_9893"/>
  </DataNode>
  <DataNode GraphId="n21_REACTOME_180326" TextLabel="SHP2:GRB2:Phospho &#10;GAB1-EGF-Phospho-&#10;EGFR (-Y992) dimer&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="1686.5" CenterY="417.0" Width="131.0" Height="64.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_13205"/>
  </DataNode>
  <DataNode GraphId="n22_REACTOME_212703" TextLabel="Activated EGFR:&#10;Phospho-PLC-&#10;gamma1&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="1147.5" CenterY="340.0" Width="99.0" Height="50.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_13347"/>
  </DataNode>
  <DataNode GraphId="n23_REACTOME_182937" TextLabel="Eps15R&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="3020.5" CenterY="359.0" Width="53.0" Height="22.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="Q9UBC2"/>
  </DataNode>
  <DataNode GraphId="n25_REACTOME_29420" TextLabel="GDP&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="480.5" CenterY="736.0" Width="41.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="17552"/>
  </DataNode>
  <DataNode GraphId="n26_REACTOME_179864" TextLabel="GRB2:GAB1:PI3Kreg&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="848.5" CenterY="750.0" Width="125.0" Height="22.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_12870"/>
  </DataNode>
  <DataNode GraphId="n27_REACTOME_180494" TextLabel="p-PAG1&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="1513.0" CenterY="315.5" Width="58.0" Height="29.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="Q9NWQ8"/>
  </DataNode>
  <DataNode GraphId="n33_REACTOME_179820" TextLabel="GRB2:SOS-EGF-&#10;Phospho-EGFR &#10;dimer&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="596.5" CenterY="548.0" Width="101.0" Height="50.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_12657"/>
  </DataNode>
  <DataNode GraphId="n34_REACTOME_167679" TextLabel="Phospho-&#10;Phospholipase C &#10;gamma 1&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="894.5" CenterY="260.0" Width="107.0" Height="50.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="P19174"/>
  </DataNode>
  <DataNode GraphId="n35_REACTOME_182915" TextLabel="Cool/Pix &#10;Ubiquitinated:&#10;CDC42-GTP&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="2477.5" CenterY="727.0" Width="89.0" Height="50.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_13061"/>
  </DataNode>
  <DataNode GraphId="n37_REACTOME_74787" TextLabel="PI3-kinase &#10;p110 &#10;subunit &#10;alpha&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="532.5" CenterY="969.0" Width="73.0" Height="22.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="P42336"/>
  </DataNode>
  <DataNode GraphId="n38_REACTOME_74686" TextLabel="GRB2&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="1056.0" CenterY="916.0" Width="40.0" Height="22.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="P62993-1"/>
  </DataNode>
  <DataNode GraphId="n39_REACTOME_182917" TextLabel="Cool/Pix:CDC42-&#10;GTP&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="2410.0" CenterY="175.0" Width="108.0" Height="36.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_12882"/>
  </DataNode>
  <DataNode GraphId="n40_REACTOME_182912" TextLabel="Sprouty&#10;" Type="Unknown">
    <Graphics Color="000000" CenterX="3567.5" CenterY="432.0" Width="51.0" Height="22.0" Valign="Middle" FillColor="ccffcc"/>
    <Xref Database="Reactome" ID="REACT_13097"/>
  </DataNode>
  <DataNode GraphId="n41_REACTOME_182911" TextLabel="EGF:Phospho-EGFR &#10;(Y1045) dimer&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="2173.0" CenterY="537.0" Width="124.0" Height="36.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_13124"/>
  </DataNode>
  <DataNode GraphId="n42_REACTOME_182909" TextLabel="Sprouty&#10;" Type="Unknown">
    <Graphics Color="000000" CenterX="3025.5" CenterY="693.0" Width="51.0" Height="22.0" Valign="Middle" FillColor="ccffcc"/>
    <Xref Database="Reactome" ID="REACT_13348"/>
  </DataNode>
  <DataNode GraphId="n43_REACTOME_109783" TextLabel="p21 RAS:GTP&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="386.0" CenterY="608.0" Width="86.0" Height="22.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_4782"/>
  </DataNode>
  <DataNode GraphId="n44_REACTOME_177480" TextLabel="Adaptor protein 2 &#10;complex&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="3149.0" CenterY="222.0" Width="116.0" Height="36.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_13288"/>
  </DataNode>
  <DataNode GraphId="n46_REACTOME_182914" TextLabel="CBL:Sprouty&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="1617.0" CenterY="808.0" Width="76.0" Height="22.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_12947"/>
  </DataNode>
  <DataNode GraphId="n48_REACTOME_112199" TextLabel="CBL&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="1425.5" CenterY="842.0" Width="29.0" Height="22.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="P22681"/>
  </DataNode>
  <DataNode GraphId="n49_REACTOME_179795" TextLabel="GAB1&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="1065.0" CenterY="825.0" Width="40.0" Height="22.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="Q13480"/>
  </DataNode>
  <DataNode GraphId="n55_REACTOME_162563" TextLabel="SHP2&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="1500.5" CenterY="703.0" Width="83.0" Height="22.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="Q06124"/>
  </DataNode>
  <DataNode GraphId="n57_REACTOME_180292" TextLabel="Gab1 signalosome&#10;" Type="Unknown">
    <Comment Source="WikiPathways-description">SHP2 down-regulates PI3K activation by dephosphorylating GAB1.</Comment>
    <BiopaxRef>lit_188658</BiopaxRef>
    <Graphics Color="000000" CenterX="1296.0" CenterY="552.0" Width="1528.0" Height="884.0" Valign="Middle" FillColor="ccffcc"/>
    <Xref Database="Reactome" ID="REACT_12578"/>
  </DataNode>
  <DataNode GraphId="n59_REACTOME_182936" TextLabel="EGF:Phospho-EGFR &#10;(Y1045) dimer:&#10;Phospho-CBL:CIN85 &#10;ubiquitinated:&#10;Endophilin:Epsin:&#10;Eps15R:Eps15 &#10;complex&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="3549.5" CenterY="551.0" Width="129.0" Height="106.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_13370"/>
  </DataNode>
  <DataNode GraphId="n60_REACTOME_179867" TextLabel="EGF:Phospho-EGFR-&#10;GRB2:GAB1:PI3Kreg&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="544.5" CenterY="835.0" Width="127.0" Height="36.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_13343"/>
  </DataNode>
  <DataNode GraphId="n61_REACTOME_177482" TextLabel="Clathrin&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="3066.0" CenterY="164.0" Width="52.0" Height="22.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_9338"/>
  </DataNode>
  <DataNode GraphId="n64_REACTOME_74680" TextLabel="SHC1&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="1236.5" CenterY="702.0" Width="39.0" Height="22.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="P29353"/>
  </DataNode>
  <DataNode GraphId="n65_REACTOME_167682" TextLabel="Phospholipase C &#10;gamma 1&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="801.5" CenterY="173.0" Width="107.0" Height="36.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="P19174"/>
  </DataNode>
  <DataNode GraphId="n66_REACTOME_182930" TextLabel="EGF:Phospho-EGFR &#10;(Y1045) dimer &#10;Ubiquitinated:&#10;Phospho-CBL&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="2899.0" CenterY="155.0" Width="124.0" Height="64.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_12986"/>
  </DataNode>
  <DataNode GraphId="n67_REACTOME_197745" TextLabel="Leucine-rich repeats &#10;and immunoglobulin-&#10;like domains protein 1 &#10;precursor&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="337.5" CenterY="208.0" Width="131.0" Height="78.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="Q96JA1"/>
  </DataNode>
  <DataNode GraphId="n68_REACTOME_182910" TextLabel="CBL:GRB2&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="2170.5" CenterY="718.0" Width="65.0" Height="22.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_13333"/>
  </DataNode>
  <DataNode GraphId="n69_REACTOME_179849" TextLabel="GRB2:GAB1&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="1314.0" CenterY="750.0" Width="76.0" Height="22.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_12705"/>
  </DataNode>
  <DataNode GraphId="n71_REACTOME_180336" TextLabel="Shc events in EGFR signaling&#10;" Type="Unknown">
    <Comment Source="WikiPathways-description">Grb2 can bind EGFR directly or through another SH2-containing protein, Shc. This association is involved in Ras activation.</Comment>
    <BiopaxRef>lit_188610</BiopaxRef>
    <BiopaxRef>lit_188605</BiopaxRef>
    <Graphics Color="000000" CenterX="721.0" CenterY="502.0" Width="1030.0" Height="482.0" Valign="Middle" FillColor="ccffcc"/>
    <Xref Database="Reactome" ID="REACT_12579"/>
  </DataNode>
  <DataNode GraphId="n72_REACTOME_179882" TextLabel="EGF:Phospho-EGFR &#10;(Y992, Y1068, &#10;Y1086, Y1148, &#10;Y1173) dimer&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="659.0" CenterY="293.0" Width="124.0" Height="64.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_9673"/>
  </DataNode>
  <DataNode GraphId="n73_REACTOME_182971" TextLabel="EGFR downregulation&#10;" Type="Unknown">
    <Comment Source="WikiPathways-description">Regulation of receptor tyrosine kinase (RTK) activity is implicated in the control of almost all cellular functions. One of the best understood RTKs is epidermal growth factor receptor (EGFR). Growth factors can bind to EGFR and activate it to initiate signalling cascades within the cell. EGFRs can also be recruited to clathrin-coated pits which can be internalised into endocytic vesicles. From here, EGFRs can either be recycled back to the plasma membrane or directed to lysosomes for destruction.This provides a mechanism by which EGFR signalling is negatively regulated and controls the strength and duration of EGFR-induced signals. It also prevents EGFR hyperactivation as commonly seen in tumorigenesis.&lt;br&gt;&lt;br&gt;The proto-oncogene Cbl can negatively regulate EGFR signalling. The Cbl family of RING-type ubiquitin ligases are able to poly-ubiquitinate EGFR, an essential step in EGFR degradation. All Cbl proteins have a unique domain that recognises phosphorylated tyrosine residues on activated EGFRs. They also direct the ubiquitination and degradation of activated EGFRs by recruiting ubiquitin-conjugation enzymes. Cbl proteins function by specifically targeting activated EGFRs and mediating their down-regulation, thus providing a means by which signaling processes can be negatively regulated.&lt;br&gt;&lt;br&gt;Cbl also promotes receptor internalization via it's interaction with an adaptor protein, CIN85 (Cbl-interacting protein of 85kDa). CIN85 binds to Cbl via it's SH3 domain and is enhanced by the EGFR-induced tyrosine phosphorylation of Cbl. The proline-rich region of CIN85 interacts with endophilins which are regulatory components of clathrin-coated vesicles (CCVs). Endophilins bind to membranes and induce membrane curvature, in conjunction with other proteins involved in CCV formation. The rapid recruitment of endophilin to the activated receptor complex by CIN85 is the mechanism which controls receptor internalization.</Comment>
    <BiopaxRef>lit_188597</BiopaxRef>
    <BiopaxRef>lit_182974</BiopaxRef>
    <BiopaxRef>lit_188598</BiopaxRef>
    <Graphics Color="000000" CenterX="2301.5" CenterY="545.5" Width="2531.0" Height="763.0" Valign="Middle" FillColor="ccffcc"/>
    <Xref Database="Reactome" ID="REACT_12484"/>
  </DataNode>
  <DataNode GraphId="n74_REACTOME_180331" TextLabel="GRB2:SOS-Phospho-&#10;SHC:EGF:Phospho-&#10;EGFR dimer&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="725.0" CenterY="545.0" Width="128.0" Height="50.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_13054"/>
  </DataNode>
  <DataNode GraphId="n76_REACTOME_182952" TextLabel="Epsin&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="3076.5" CenterY="358.0" Width="39.0" Height="22.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="Q9Y6I3"/>
  </DataNode>
  <DataNode GraphId="n78_REACTOME_109797" TextLabel="GRB2:SOS1&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="957.5" CenterY="709.0" Width="65.0" Height="22.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_4435"/>
  </DataNode>
  <DataNode GraphId="n80_REACTOME_182941" TextLabel="EGF:Phospho-EGFR &#10;(Y1045) dimer:&#10;Phospho-CBL:GRB2:&#10;CIN85:Endophilin:&#10;Epsin:Eps15R:Eps15 &#10;complex:Clathrin&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="3334.5" CenterY="277.0" Width="133.0" Height="92.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_13237"/>
  </DataNode>
  <DataNode GraphId="n81_REACTOME_182946" TextLabel="EGF:Phospho-EGFR &#10;(Y1045) dimer:&#10;Phospho-CBL:GRB2:&#10;CIN85:Endophilin&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="2837.5" CenterY="458.0" Width="125.0" Height="64.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_12726"/>
  </DataNode>
  <DataNode GraphId="n82_REACTOME_179812" TextLabel="Grb2 events in EGFR signaling&#10;" Type="Unknown">
    <Comment Source="WikiPathways-description">Autophosphorylation of tyrosine residues are docking sites for many downstream effectors in EGFR signaling. SH2-containing phosphotyrosine-binding domains of adaptor proteins like GRB2 is one such example. GRB2 is constitutively associated with SOS, a guanine nucleotide exchange factor of Ras. GRB2 binding to phosphorylated EGFR results in the recruitment of SOS to the plasma membrane where it comes in proximity to Ras. This mechanism has been seen to be the model for Ras activation.</Comment>
    <BiopaxRef>lit_188639</BiopaxRef>
    <BiopaxRef>lit_188610</BiopaxRef>
    <Graphics Color="000000" CenterX="631.0" CenterY="596.0" Width="850.0" Height="670.0" Valign="Middle" FillColor="ccffcc"/>
    <Xref Database="Reactome" ID="REACT_12606"/>
  </DataNode>
  <DataNode GraphId="n83_REACTOME_182960" TextLabel="EGF:Phospho-EGFR &#10;(Y1045) dimer:CBL&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="2456.0" CenterY="444.0" Width="124.0" Height="36.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_12959"/>
  </DataNode>
  <DataNode GraphId="n85_REACTOME_29438" TextLabel="GTP&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="761.0" CenterY="712.0" Width="40.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="15996"/>
  </DataNode>
  <DataNode GraphId="n87_REACTOME_182928" TextLabel="EGF:Phospho-EGFR &#10;(Y1045) dimer:CBL:&#10;GRB2&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="2367.0" CenterY="625.0" Width="124.0" Height="50.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_13163"/>
  </DataNode>
  <DataNode GraphId="n88_REACTOME_182955" TextLabel="CIN85&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="2623.0" CenterY="178.0" Width="44.0" Height="22.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="Q96B97"/>
  </DataNode>
  <DataNode GraphId="n90_REACTOME_180301" TextLabel="EGF:Phospho-EGFR-&#10;SHC&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="1159.5" CenterY="439.0" Width="127.0" Height="36.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_12643"/>
  </DataNode>
  <DataNode GraphId="n95_REACTOME_182942" TextLabel="CBL:Cool/Pix&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="1708.5" CenterY="811.0" Width="81.0" Height="22.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_13162"/>
  </DataNode>
  <DataNode GraphId="n96_REACTOME_179791" TextLabel="EGF:Phospho-EGFR-&#10;GRB2:GAB1:PI3Kreg:&#10;PI3Kcat&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="759.5" CenterY="904.0" Width="129.0" Height="50.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_12738"/>
  </DataNode>
  <DataNode GraphId="n97_REACTOME_212718" TextLabel="EGFR interacts with phospholipase C-gamma&#10;" Type="Unknown">
    <Comment Source="WikiPathways-description">Activated epidermal growth factor receptors (EGFR) can stimulate phosphatidylinositol (PI) turnover. Activated EGFR can activate phospholipase C-gamma1 (PLC-gamma1) which hydrolyses phosphatidylinositol 4,5-bisphosphate (PIP2) to inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG). IP3 is instrumental in the release of calcium from intracellular stores and DAG is involved in protein kinase C activation.</Comment>
    <BiopaxRef>lit_213067</BiopaxRef>
    <Graphics Color="000000" CenterX="943.0" CenterY="237.5" Width="568.0" Height="205.0" Valign="Middle" FillColor="ccffcc"/>
    <Xref Database="Reactome" ID="REACT_12478"/>
  </DataNode>
  <DataNode GraphId="n99_REACTOME_109787" TextLabel="p-Raf1(S259,S621):&#10;14-3-3 protein &#10;beta/alpha&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="374.0" CenterY="730.0" Width="126.0" Height="50.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_4612"/>
  </DataNode>
  <DataNode GraphId="n100_REACTOME_112192" TextLabel="CBL&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="2244.5" CenterY="295.0" Width="29.0" Height="22.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="P22681"/>
  </DataNode>
  <DataNode GraphId="n101_REACTOME_182943" TextLabel="EGF:Phospho-EGFR &#10;(Y1045) dimer:CBL:&#10;CIN85&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="2398.0" CenterY="306.0" Width="124.0" Height="50.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_13382"/>
  </DataNode>
  <DataNode GraphId="n102_REACTOME_182950" TextLabel="Y55-phospho &#10;Sprouty 2&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="1442.0" CenterY="765.0" Width="92.0" Height="36.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="O43597"/>
  </DataNode>
  <DataNode GraphId="n103_REACTOME_182945" TextLabel="EGF:Phospho-EGFR &#10;(Y1045) dimer &#10;Ubiquitinated:&#10;Phospho-CBL:GRB2&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="2882.0" CenterY="623.0" Width="124.0" Height="64.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_12838"/>
  </DataNode>
  <DataNode GraphId="n105_REACTOME_64847" TextLabel="Son of sevenless &#10;protein homolog 1&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="892.0" CenterY="931.0" Width="114.0" Height="36.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="Q07889"/>
  </DataNode>
  <DataNode GraphId="n106_REACTOME_180348" TextLabel="GAB1:GRB2-EGF-&#10;Phospho-EGFR &#10;dimer&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="1327.0" CenterY="304.0" Width="112.0" Height="50.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_13196"/>
  </DataNode>
  <DataNode GraphId="n107_REACTOME_182953" TextLabel="EGF:Phospho-EGFR &#10;(Y1045) dimer:&#10;Phospho-CBL&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="2859.0" CenterY="314.0" Width="124.0" Height="50.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_13081"/>
  </DataNode>
  <DataNode GraphId="n108_REACTOME_182947" TextLabel="Eps15:HGS:STAM&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="3153.5" CenterY="727.0" Width="109.0" Height="22.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_12763"/>
  </DataNode>
  <DataNode GraphId="n109_REACTOME_182932" TextLabel="EGF:Phospho-EGFR &#10;(Y1045) dimer:CBL:&#10;Cool/Pix:CDC42-GTP&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="2668.0" CenterY="290.0" Width="124.0" Height="64.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_12733"/>
  </DataNode>
  <DataNode GraphId="n112_REACTOME_180337" TextLabel="EGF:Phospho-EGFR:&#10;Phospho-SHC&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="1047.0" CenterY="538.0" Width="124.0" Height="36.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_12720"/>
  </DataNode>
  <DataNode GraphId="n114_REACTOME_182938" TextLabel="CBL:Sprouty&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="2199.0" CenterY="156.0" Width="76.0" Height="22.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_13051"/>
  </DataNode>
  <DataNode GraphId="n115_REACTOME_109796" TextLabel="p21 RAS:GDP&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="747.5" CenterY="618.0" Width="87.0" Height="22.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_2657"/>
  </DataNode>
  <DataNode GraphId="n117_REACTOME_48888" TextLabel="14-3-3 protein &#10;beta/alpha&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="207.5" CenterY="743.0" Width="103.0" Height="36.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="P31946"/>
  </DataNode>
  <DataNode GraphId="n118_REACTOME_65043" TextLabel="SRC&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="539.0" CenterY="199.0" Width="30.0" Height="22.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="P12931-1"/>
  </DataNode>
  <DataNode GraphId="n120_REACTOME_182961" TextLabel="EGF:Phospho-EGFR &#10;(Y1045) dimer:&#10;Phospho-CBL:CIN85:&#10;Endophilin:Epsin:&#10;Eps15R:Eps15 &#10;complex&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="3398.5" CenterY="433.0" Width="129.0" Height="92.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_13366"/>
  </DataNode>
  <DataNode GraphId="n122_REACTOME_180499" TextLabel="Tyrosine-protein &#10;kinase CSK&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="1996.5" CenterY="446.0" Width="109.0" Height="36.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="P41240"/>
  </DataNode>
  <DataNode GraphId="n124_REACTOME_183070" TextLabel="Y55-phospho &#10;Sprouty 2&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="2122.0" CenterY="294.0" Width="92.0" Height="36.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="O43597"/>
  </DataNode>
  <DataNode GraphId="n125_REACTOME_179838" TextLabel="Phosphatidylinositol-&#10;3,4,5-trisphosphate&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="1510.0" CenterY="165.0" Width="136.0" Height="44.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="16618"/>
  </DataNode>
  <DataNode GraphId="n127_REACTOME_180286" TextLabel="GRB2:Phospho &#10;GAB1-EGF-&#10;Phospho-EGFR &#10;dimer&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="1490.0" CenterY="504.0" Width="98.0" Height="64.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_12983"/>
  </DataNode>
  <DataNode GraphId="n129_REACTOME_182948" TextLabel="EGF:Phospho-EGFR &#10;(Y1045) dimer:&#10;Phospho-CBL:GRB2&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="2719.0" CenterY="629.0" Width="124.0" Height="50.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_13256"/>
  </DataNode>
  <DataNode GraphId="n130_REACTOME_180503" TextLabel="SHP2-GRB2:Phospho &#10;GAB1(dephos)-EGF-&#10;Phospho-EGFR dimer&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="1963.0" CenterY="578.0" Width="134.0" Height="64.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_12652"/>
  </DataNode>
  <DataNode GraphId="n131_REACTOME_182931" TextLabel="EGF:Phospho-EGFR &#10;(Y1045) dimer:&#10;Phospho-CBL:CIN85-&#10;Sprouty:Endophilin:&#10;Epsin:Eps15R:Eps15 &#10;complex&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="3496.0" CenterY="162.0" Width="124.0" Height="106.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_12661"/>
  </DataNode>
  <DataNode GraphId="n132_REACTOME_182934" TextLabel="CIN85:Endophilin&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="2984.0" CenterY="739.0" Width="108.0" Height="22.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_12741"/>
  </DataNode>
  <DataNode GraphId="n133_REACTOME_179863" TextLabel="EGF&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="183.0" CenterY="32.0" Width="30.0" Height="22.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="P01133"/>
  </DataNode>
  <DataNode GraphId="n134_REACTOME_212717" TextLabel="Activated EGFR:PLC-&#10;gamma1&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="996.5" CenterY="214.0" Width="127.0" Height="36.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_13280"/>
  </DataNode>
  <DataNode GraphId="n136_REACTOME_113595" TextLabel="ubiquitin&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="2835.0" CenterY="780.0" Width="58.0" Height="22.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="Reactome" ID="REACT_3316"/>
  </DataNode>
  <DataNode GraphId="n137_REACTOME_180523" TextLabel="Paxillin:Src complex&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="1989.0" CenterY="299.0" Width="122.0" Height="22.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_13128"/>
  </DataNode>
  <DataNode GraphId="n141_REACTOME_179842" TextLabel="ADAM &#10;metalloprotease:Zinc &#10;cofactor&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="100.0" CenterY="211.0" Width="132.0" Height="50.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_9655"/>
  </DataNode>
  <DataNode GraphId="n142_REACTOME_182935" TextLabel="EGF:Phospho-EGFR &#10;dimer:CBL:Phospho-&#10;Sprouty&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="3232.5" CenterY="593.0" Width="127.0" Height="50.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_13028"/>
  </DataNode>
  <DataNode GraphId="n143_REACTOME_180282" TextLabel="PIP3:GAB1:GRB2-&#10;EGF-Phospho-EGFR &#10;dimer&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="1309.5" CenterY="131.0" Width="127.0" Height="50.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_13218"/>
  </DataNode>
  <DataNode GraphId="n145_REACTOME_182921" TextLabel="CDC42-GTP&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="1714.0" CenterY="701.0" Width="80.0" Height="22.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_12889"/>
  </DataNode>
  <DataNode GraphId="n581_REACTOME_179856" TextLabel="Phosphatidylinositol-&#10;4,5-bisphosphate&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="2985.0" CenterY="232.0" Width="136.0" Height="44.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="18348"/>
  </DataNode>
  <DataNode GraphId="n582_REACTOME_113592" TextLabel="ATP&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="1098.5" CenterY="259.0" Width="39.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="15422"/>
  </DataNode>
  <DataNode GraphId="n583_REACTOME_29370" TextLabel="ADP&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="1227.0" CenterY="262.0" Width="40.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="16761"/>
  </DataNode>
  <DataNode GraphId="n584_REACTOME_113592" TextLabel="ATP&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="1209.5" CenterY="501.0" Width="39.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="15422"/>
  </DataNode>
  <DataNode GraphId="n585_REACTOME_29370" TextLabel="ADP&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="1133.0" CenterY="604.0" Width="40.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="16761"/>
  </DataNode>
  <DataNode GraphId="n586_REACTOME_113592" TextLabel="ATP&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="2666.5" CenterY="445.0" Width="39.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="15422"/>
  </DataNode>
  <DataNode GraphId="n587_REACTOME_29370" TextLabel="ADP&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="2779.0" CenterY="244.0" Width="40.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="16761"/>
  </DataNode>
  <DataNode GraphId="n588_REACTOME_29356" TextLabel="H2O&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="1730.0" CenterY="522.0" Width="42.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="15377"/>
  </DataNode>
  <DataNode GraphId="n589_REACTOME_29372" TextLabel="Orthophosphate&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="1766.5" CenterY="478.0" Width="109.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="18367"/>
  </DataNode>
  <DataNode GraphId="n590_REACTOME_29356" TextLabel="H2O&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="1843.0" CenterY="414.0" Width="42.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="15377"/>
  </DataNode>
  <DataNode GraphId="n591_REACTOME_29372" TextLabel="Orthophosphate&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="1866.5" CenterY="276.0" Width="109.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="18367"/>
  </DataNode>
  <DataNode GraphId="n592_REACTOME_113592" TextLabel="ATP&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="715.5" CenterY="141.0" Width="39.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="15422"/>
  </DataNode>
  <DataNode GraphId="n593_REACTOME_29370" TextLabel="ADP&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="731.0" CenterY="233.0" Width="40.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="16761"/>
  </DataNode>
  <DataNode GraphId="n594_REACTOME_113592" TextLabel="ATP&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="2479.5" CenterY="562.0" Width="39.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="15422"/>
  </DataNode>
  <DataNode GraphId="n595_REACTOME_29370" TextLabel="ADP&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="2589.0" CenterY="579.0" Width="40.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="16761"/>
  </DataNode>
  <DataNode GraphId="n596_REACTOME_29356" TextLabel="H2O&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="1506.0" CenterY="387.0" Width="42.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="15377"/>
  </DataNode>
  <DataNode GraphId="n597_REACTOME_29372" TextLabel="Orthophosphate&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="1591.5" CenterY="284.0" Width="109.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="18367"/>
  </DataNode>
  <DataNode GraphId="n598_REACTOME_113592" TextLabel="ATP&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="1378.5" CenterY="419.0" Width="39.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="15422"/>
  </DataNode>
  <DataNode GraphId="n599_REACTOME_29370" TextLabel="ADP&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="1421.0" CenterY="558.0" Width="40.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="16761"/>
  </DataNode>
  <DataNode GraphId="n600_REACTOME_113592" TextLabel="ATP&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="575.5" CenterY="153.0" Width="39.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="15422"/>
  </DataNode>
  <DataNode GraphId="n601_REACTOME_29370" TextLabel="ADP&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="563.0" CenterY="238.0" Width="40.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="16761"/>
  </DataNode>
  <DataNode GraphId="n602_REACTOME_29356" TextLabel="H2O&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="1771.0" CenterY="617.0" Width="42.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="15377"/>
  </DataNode>
  <DataNode GraphId="n603_REACTOME_29372" TextLabel="Orthophosphate&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="1867.5" CenterY="524.0" Width="109.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="18367"/>
  </DataNode>
  <DataNode GraphId="n604_REACTOME_113592" TextLabel="ATP&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="1857.5" CenterY="123.0" Width="39.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="15422"/>
  </DataNode>
  <DataNode GraphId="n605_REACTOME_29370" TextLabel="ADP&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="1602.0" CenterY="110.0" Width="40.0" Height="30.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="16761"/>
  </DataNode>
  <DataNode GraphId="n609_REACTOME_110029" TextLabel="RAF activation&#10;" Type="Pathway">
    <Comment Source="WikiPathways-description">Phosphorylated RAF is activated by Ras binding and stabilised in its active form by transient disassociation and reassociation of 14-3-3, as well as further phosphorylation.</Comment>
    <BiopaxRef>lit_110028</BiopaxRef>
    <Graphics Color="000000" CenterX="785.5" CenterY="98.5" Width="97.0" Height="29.0" Valign="Middle" FillColor="ccffcc"/>
    <Xref Database="Reactome" ID="REACT_2077"/>
  </DataNode>
  <DataNode GraphId="n616_REACTOME_109869" TextLabel="MAP kinase cascade&#10;" Type="Pathway">
    <Comment Source="WikiPathways-description">The MAP kinase cascade describes a sequence of phosphorylation events involving serine/threonine-specific protein kinases. Used by various signal transduction pathways, this cascade constitutes a common 'module' in the transmission of an extracellular signal into the nucleus.</Comment>
    <Graphics Color="000000" CenterX="118.0" CenterY="1067.0" Width="174.0" Height="56.0" Valign="Middle" FillColor="ccffcc"/>
    <Xref Database="Reactome" ID="REACT_634"/>
  </DataNode>
  <DataNode GraphId="n618_REACTOME_109786" TextLabel="p-Raf1(S259,&#10;S621)&#10;" Type="Protein">
    <Graphics Color="000000" CenterX="199.5" CenterY="815.5" Width="109.0" Height="21.0" Valign="Middle" FillColor="ccffcc" ShapeType="RoundedRectangle"/>
    <Xref Database="UniProt" ID="P04049"/>
  </DataNode>
  <DataNode GraphId="n620_REACTOME_109789" TextLabel="RAS:RAF:14-3-&#10;3&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="161.5" CenterY="556.5" Width="97.0" Height="21.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_3642"/>
  </DataNode>
  <DataNode GraphId="n622_REACTOME_113592" TextLabel="ATP&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="91.5" CenterY="707.5" Width="37.0" Height="29.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="15422"/>
  </DataNode>
  <DataNode GraphId="n623_REACTOME_109793" TextLabel="Activated RAF1 &#10;complex&#10;" Type="Complex">
    <Graphics Color="000000" CenterX="159.0" CenterY="445.5" Width="98.0" Height="35.0" Valign="Middle" FillColor="ccffff" ShapeType="RoundedRectangle" LineThickness="2"/>
    <Xref Database="Reactome" ID="REACT_4906"/>
  </DataNode>
  <DataNode GraphId="n624_REACTOME_29370" TextLabel="ADP&#10;" Type="Metabolite">
    <Graphics Color="000000" CenterX="64.5" CenterY="774.5" Width="39.0" Height="29.0" Valign="Middle" FillColor="ccffcc" ShapeType="Oval"/>
    <Xref Database="ChEBI" ID="16761"/>
  </DataNode>
  <DataNode GraphId="n625_REACTOME_163338" TextLabel="unidentified protein &#10;tyrosine kinase&#10;" Type="Unknown">
    <Graphics Color="000000" CenterX="204.5" CenterY="516.5" Width="121.0" Height="35.0" Valign="Middle" FillColor="ccffcc"/>
    <Xref Database="Reactome" ID="REACT_4938"/>
  </DataNode>
  <Line GraphId="e_6_REACTOME_182986">
    <Comment Source="WikiPathways-description">The adaptor protein CIN85 is monoubiquitinated by CBL after EGF stimulation. Monoubiquitination is thought to regulate receptor internalization and endosomal sorting.</Comment>
    <BiopaxRef>lit_188579</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="3354.0" Y="549.0" GraphId="e_6_0"/>
      <Point X="3402.0" Y="549.0" GraphId="e_6_1"/>
      <Point X="3482.0" Y="550.0" GraphId="e_6_2" GraphRef="n59_REACTOME_182936" RelX="-1.0387596899224807" RelY="-0.018867924528301886" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_6_a_i"/>
      <Anchor Position="0.374981691062281" GraphId="e_6_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_6_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="3363.0" Y="482.0" GraphId="e_6_i0_0" GraphRef="n120_REACTOME_182961" RelX="-0.5426356589147286" RelY="1.065217391304348"/>
      <Point X="3354.0" Y="491.0" GraphId="e_6_i0_1"/>
      <Point X="3354.0" Y="549.0" GraphId="e_6_i0_2" GraphRef="e_6_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_6_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2867.0" Y="779.0" GraphId="e_6_i1_0" GraphRef="n136_REACTOME_113595" RelX="1.103448275862069" RelY="-0.09090909090909091"/>
      <Point X="3355.0" Y="778.0" GraphId="e_6_i1_1"/>
      <Point X="3354.0" Y="549.0" GraphId="e_6_i1_2" GraphRef="e_6_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_6_c__0">
    <Graphics LineStyle="Broken" Color="000000" ConnectorType="Segmented">
      <Point X="3399.0" Y="482.0" GraphId="e_6_c__0_0" GraphRef="n120_REACTOME_182961" RelX="0.015503875968992248" RelY="1.065217391304348"/>
      <Point X="3402.0" Y="549.0" GraphId="e_6_c__0_1" GraphRef="e_6_a_p" ArrowHead="Line"/>
    </Graphics>
  </Line>
  <Line GraphId="e_7_REACTOME_183036">
    <Comment Source="WikiPathways-description">CBL down-regulates receptor tyrosine kinases by conjugating ubiquitin to them. This leads to receptor internalization and degradation. The ubiquitin protein ligase activity of CBL (abbreviated as E3 activity) is mediated by its RING finger domain.</Comment>
    <BiopaxRef>lit_183078</BiopaxRef>
    <BiopaxRef>lit_182974</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2833.0" Y="690.0" GraphId="e_7_0"/>
      <Point X="2887.0" Y="690.0" GraphId="e_7_1"/>
      <Point X="2884.0" Y="658.0" GraphId="e_7_2" GraphRef="n103_REACTOME_182945" RelX="0.03225806451612903" RelY="1.09375" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_7_a_i"/>
      <Anchor Position="0.6268841543076339" GraphId="e_7_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_7_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2765.0" Y="657.0" GraphId="e_7_i0_0" GraphRef="n129_REACTOME_182948" RelX="0.7419354838709677" RelY="1.12"/>
      <Point X="2833.0" Y="690.0" GraphId="e_7_i0_1" GraphRef="e_7_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_7_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2834.0" Y="766.0" GraphId="e_7_i1_0" GraphRef="n136_REACTOME_113595" RelX="-0.034482758620689655" RelY="-1.2727272727272727"/>
      <Point X="2833.0" Y="690.0" GraphId="e_7_i1_1" GraphRef="e_7_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_7_c__0">
    <Graphics LineStyle="Broken" Color="000000" ConnectorType="Segmented">
      <Point X="2784.0" Y="651.0" GraphId="e_7_c__0_0" GraphRef="n129_REACTOME_182948" RelX="1.0483870967741935" RelY="0.88"/>
      <Point X="2887.0" Y="690.0" GraphId="e_7_c__0_1" GraphRef="e_7_a_p" ArrowHead="Line"/>
    </Graphics>
  </Line>
  <Line GraphId="e_10_REACTOME_212713">
    <Comment Source="WikiPathways-description">Once activated PLC-gamma1 dissociates from EGFR, it can hydrolyze PIP2.</Comment>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1095.0" Y="336.0" GraphId="e_10_0" GraphRef="n22_REACTOME_212703" RelX="-1.0505050505050506" RelY="-0.16"/>
      <Point X="950.0" Y="326.0" GraphId="e_10_1"/>
      <Point X="799.0" Y="287.0" GraphId="e_10_2"/>
      <Anchor Position="0.482391769993721" GraphId="e_10_a_p"/>
      <Anchor Position="1.0" GraphId="e_10_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_10_o0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="724.0" Y="290.0" GraphId="e_10_o0_0" ArrowHead="Arrow" GraphRef="n72_REACTOME_179882" RelX="1.0483870967741935" RelY="-0.09375"/>
      <Point X="799.0" Y="287.0" GraphId="e_10_o0_1" GraphRef="e_10_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_10_o1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="838.0" Y="275.0" GraphId="e_10_o1_0" ArrowHead="Arrow" GraphRef="n34_REACTOME_167679" RelX="-1.0467289719626167" RelY="0.6"/>
      <Point X="799.0" Y="287.0" GraphId="e_10_o1_1" GraphRef="e_10_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_11_REACTOME_212710">
    <Comment Source="WikiPathways-description">EGFR phosphorylates PLC-gamma1, thus activating it.</Comment>
    <BiopaxRef>lit_212708</BiopaxRef>
    <BiopaxRef>lit_212704</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1097.0" Y="213.0" GraphId="e_11_0"/>
      <Point X="1146.0" Y="213.0" GraphId="e_11_1"/>
      <Point X="1146.0" Y="262.0" GraphId="e_11_2"/>
      <Anchor Position="0.0" GraphId="e_11_a_i"/>
      <Anchor Position="0.5" GraphId="e_11_a_p"/>
      <Anchor Position="1.0" GraphId="e_11_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_11_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1063.0" Y="213.0" GraphId="e_11_i0_0" GraphRef="n134_REACTOME_212717" RelX="1.0551181102362204" RelY="-0.05555555555555555"/>
      <Point X="1097.0" Y="213.0" GraphId="e_11_i0_1" GraphRef="e_11_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_11_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1097.0" Y="241.0" GraphId="e_11_i1_0" GraphRef="n582_REACTOME_113592" RelX="-0.05128205128205128" RelY="-1.2"/>
      <Point X="1097.0" Y="213.0" GraphId="e_11_i1_1" GraphRef="e_11_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_11_o0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1204.0" Y="262.0" GraphId="e_11_o0_0" ArrowHead="Arrow" GraphRef="n583_REACTOME_29370" RelX="-1.15" RelY="0.0"/>
      <Point X="1146.0" Y="262.0" GraphId="e_11_o0_1" GraphRef="e_11_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_11_o1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1146.0" Y="312.0" GraphId="e_11_o1_0" ArrowHead="Arrow" GraphRef="n22_REACTOME_212703" RelX="-0.020202020202020204" RelY="-1.12"/>
      <Point X="1146.0" Y="262.0" GraphId="e_11_o1_1" GraphRef="e_11_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_11_c__0">
    <Graphics LineStyle="Broken" Color="000000" ConnectorType="Segmented">
      <Point X="995.0" Y="193.0" GraphId="e_11_c__0_0" GraphRef="n134_REACTOME_212717" RelX="-0.015748031496062992" RelY="-1.1666666666666667"/>
      <Point X="995.0" Y="135.0" GraphId="e_11_c__0_1"/>
      <Point X="1146.0" Y="135.0" GraphId="e_11_c__0_2"/>
      <Point X="1146.0" Y="213.0" GraphId="e_11_c__0_3" GraphRef="e_11_a_p" ArrowHead="Line"/>
    </Graphics>
  </Line>
  <Line GraphId="e_13_REACTOME_177927">
    <Comment Source="WikiPathways-description">The 110 kDa catalytic subunit binds to the 85 kDa regulatory subunit to create the active PI3K.</Comment>
    <BiopaxRef>lit_179899</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="578.0" Y="904.0" GraphId="e_13_0"/>
      <Point X="648.0" Y="904.0" GraphId="e_13_1"/>
      <Point X="692.0" Y="904.0" GraphId="e_13_2" GraphRef="n96_REACTOME_179791" RelX="-1.0387596899224807" RelY="0.0" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_13_a_i"/>
      <Anchor Position="0.6140350877192983" GraphId="e_13_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_13_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="552.0" Y="856.0" GraphId="e_13_i0_0" GraphRef="n60_REACTOME_179867" RelX="0.12598425196850394" RelY="1.1666666666666667"/>
      <Point X="578.0" Y="904.0" GraphId="e_13_i0_1" GraphRef="e_13_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_13_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="539.0" Y="955.0" GraphId="e_13_i1_0" GraphRef="n37_REACTOME_74787" RelX="0.1917808219178082" RelY="-1.2727272727272727"/>
      <Point X="578.0" Y="904.0" GraphId="e_13_i1_1" GraphRef="e_13_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_17_REACTOME_183094">
    <Comment Source="WikiPathways-description">Activated CDC42 binds to p85Cool-1/beta-Pix, a protein that directly associates with CBL. This inhibits the binding of CBL by the EGF receptor and thus prevents CBL from catalyzing receptor ubiquitination.</Comment>
    <BiopaxRef>lit_183080</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1744.0" Y="761.0" GraphId="e_17_0"/>
      <Point X="1799.0" Y="761.0" GraphId="e_17_1"/>
      <Point X="1859.0" Y="761.0" GraphId="e_17_2" GraphRef="n15_REACTOME_182956" RelX="-1.0588235294117647" RelY="-0.05555555555555555" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_17_a_i"/>
      <Anchor Position="0.4782608695652174" GraphId="e_17_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_17_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1715.0" Y="797.0" GraphId="e_17_i0_0" GraphRef="n95_REACTOME_182942" RelX="0.1728395061728395" RelY="-1.2727272727272727"/>
      <Point X="1744.0" Y="761.0" GraphId="e_17_i0_1" GraphRef="e_17_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_17_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1719.0" Y="715.0" GraphId="e_17_i1_0" GraphRef="n145_REACTOME_182921" RelX="0.125" RelY="1.2727272727272727"/>
      <Point X="1744.0" Y="761.0" GraphId="e_17_i1_1" GraphRef="e_17_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_18_REACTOME_177920">
    <Comment Source="WikiPathways-description">GRB2 (Growth factor receptor-bound protein 2) binds to GAB1 (GRB2-associated binding protein 1).</Comment>
    <BiopaxRef>lit_179886</BiopaxRef>
    <BiopaxRef>lit_188664</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1090.0" Y="873.0" GraphId="e_18_0"/>
      <Point X="1313.0" Y="873.0" GraphId="e_18_1"/>
      <Point X="1313.0" Y="764.0" GraphId="e_18_2" GraphRef="n69_REACTOME_179849" RelX="-0.02631578947368421" RelY="1.2727272727272727" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_18_a_i"/>
      <Anchor Position="0.6716867469879518" GraphId="e_18_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_18_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1064.0" Y="902.0" GraphId="e_18_i0_0" GraphRef="n38_REACTOME_74686" RelX="0.4" RelY="-1.2727272727272727"/>
      <Point X="1090.0" Y="873.0" GraphId="e_18_i0_1" GraphRef="e_18_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_18_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1070.0" Y="839.0" GraphId="e_18_i1_0" GraphRef="n49_REACTOME_179795" RelX="0.25" RelY="1.2727272727272727"/>
      <Point X="1090.0" Y="873.0" GraphId="e_18_i1_1" GraphRef="e_18_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_24_REACTOME_183067">
    <Comment Source="WikiPathways-description">Upon EGF stimulation and consequent EGFR phosphorylation, GRB2 binds phosphorylated tyrosines</Comment>
    <BiopaxRef>lit_183098</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2190.0" Y="624.0" GraphId="e_24_0"/>
      <Point X="2246.0" Y="624.0" GraphId="e_24_1"/>
      <Point X="2302.0" Y="624.0" GraphId="e_24_2" GraphRef="n87_REACTOME_182928" RelX="-1.0483870967741935" RelY="-0.04" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_24_a_i"/>
      <Anchor Position="0.5" GraphId="e_24_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_24_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2172.0" Y="704.0" GraphId="e_24_i0_0" GraphRef="n68_REACTOME_182910" RelX="0.06153846153846154" RelY="-1.2727272727272727"/>
      <Point X="2190.0" Y="624.0" GraphId="e_24_i0_1" GraphRef="e_24_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_24_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2176.0" Y="558.0" GraphId="e_24_i1_0" GraphRef="n41_REACTOME_182911" RelX="0.04838709677419355" RelY="1.1666666666666667"/>
      <Point X="2190.0" Y="624.0" GraphId="e_24_i1_1" GraphRef="e_24_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_28_REACTOME_177933">
    <Comment Source="WikiPathways-description">Once bound to EGFR, SHC is phosphorylated on two tyrosines (Y349, Y350).</Comment>
    <BiopaxRef>lit_180308</BiopaxRef>
    <BiopaxRef>lit_180313</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1169.0" Y="501.0" GraphId="e_28_0"/>
      <Point X="1170.0" Y="543.0" GraphId="e_28_1"/>
      <Point X="1153.0" Y="543.0" GraphId="e_28_2"/>
      <Point X="1132.0" Y="543.0" GraphId="e_28_3"/>
      <Anchor Position="0.0" GraphId="e_28_a_i"/>
      <Anchor Position="0.7375390511551396" GraphId="e_28_a_p"/>
      <Anchor Position="1.0" GraphId="e_28_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_28_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1161.0" Y="460.0" GraphId="e_28_i0_0" GraphRef="n90_REACTOME_180301" RelX="0.031496062992125984" RelY="1.1666666666666667"/>
      <Point X="1169.0" Y="501.0" GraphId="e_28_i0_1" GraphRef="e_28_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_28_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1187.0" Y="501.0" GraphId="e_28_i1_0" GraphRef="n584_REACTOME_113592" RelX="-1.1282051282051282" RelY="0.0"/>
      <Point X="1169.0" Y="501.0" GraphId="e_28_i1_1" GraphRef="e_28_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_28_o0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1112.0" Y="541.0" GraphId="e_28_o0_0" ArrowHead="Arrow" GraphRef="n112_REACTOME_180337" RelX="1.0483870967741935" RelY="0.16666666666666666"/>
      <Point X="1132.0" Y="543.0" GraphId="e_28_o0_1" GraphRef="e_28_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_28_o1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1132.0" Y="586.0" GraphId="e_28_o1_0" ArrowHead="Arrow" GraphRef="n585_REACTOME_29370" RelX="-0.05" RelY="-1.2"/>
      <Point X="1132.0" Y="543.0" GraphId="e_28_o1_1" GraphRef="e_28_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_28_c__0">
    <Graphics LineStyle="Broken" Color="000000" ConnectorType="Segmented">
      <Point X="1155.0" Y="460.0" GraphId="e_28_c__0_0" GraphRef="n90_REACTOME_180301" RelX="-0.06299212598425197" RelY="1.1666666666666667"/>
      <Point X="1152.0" Y="476.0" GraphId="e_28_c__0_1"/>
      <Point X="1153.0" Y="543.0" GraphId="e_28_c__0_2" GraphRef="e_28_a_p" ArrowHead="Line"/>
    </Graphics>
  </Line>
  <Line GraphId="e_29_REACTOME_177946">
    <Comment Source="WikiPathways-description">Ligands of the epidermal growth factor receptor (EGFR)  are shed from the plasma membrane by metalloproteases.  Identification of the sheddases for EGFR ligands using mouse embryonic cells lacking candidate sheddases (a disintegrin and metalloprotease; ADAM) has revealed that ADAM10, -12 and -17 are the sheddases of the EGFR ligands in response to various shedding stimulants such as GPCR agonists, growth factors, cytokines, osmotic stress, wounding and phorbol ester. Among the EGFR ligands, heparin-binding EGF-like growth factor (HB-EGF), EGF and TGF-alpha are the best characterized.</Comment>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="160.0" Y="108.0" GraphId="e_29_0" GraphRef="n2_REACTOME_179888" RelX="1.0598290598290598" RelY="-0.09090909090909091"/>
      <Point X="182.0" Y="108.0" GraphId="e_29_1"/>
      <Point X="182.0" Y="46.0" GraphId="e_29_2" GraphRef="n133_REACTOME_179863" RelX="-0.06666666666666667" RelY="1.2727272727272727" ArrowHead="Arrow"/>
      <Anchor Position="0.2619047619047619" GraphId="e_29_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_29_c__0">
    <Graphics LineStyle="Broken" Color="000000" ConnectorType="Segmented">
      <Point X="169.0" Y="211.0" GraphId="e_29_c__0_0" GraphRef="n141_REACTOME_179842" RelX="1.0454545454545454" RelY="0.0"/>
      <Point X="182.0" Y="211.0" GraphId="e_29_c__0_1"/>
      <Point X="182.0" Y="108.0" GraphId="e_29_c__0_2" GraphRef="e_29_a_p" ArrowHead="Line"/>
    </Graphics>
  </Line>
  <Line GraphId="e_30_REACTOME_177942">
    <Comment Source="WikiPathways-description">The prototypic receptor tyrosine kinase (RTK) EGFR is composed of 3 major domains; an extracellular domain linked via a single membrane-spanning domain to a cytoplasmic domain. EGF binds to the extracellular domain from where the signal is transmitted to the cytoplasmic domain.</Comment>
    <BiopaxRef>lit_188642</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="225.0" Y="95.0" GraphId="e_30_0"/>
      <Point X="336.0" Y="95.0" GraphId="e_30_1"/>
      <Point X="437.0" Y="95.0" GraphId="e_30_2" GraphRef="n20_REACTOME_179847" RelX="-1.09375" RelY="-0.09090909090909091" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_30_a_i"/>
      <Anchor Position="0.5235849056603774" GraphId="e_30_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_30_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="201.0" Y="32.0" GraphId="e_30_i0_0" GraphRef="n133_REACTOME_179863" RelX="1.2" RelY="0.0"/>
      <Point X="225.0" Y="33.0" GraphId="e_30_i0_1"/>
      <Point X="225.0" Y="95.0" GraphId="e_30_i0_2" GraphRef="e_30_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_30_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="225.0" Y="133.0" GraphId="e_30_i1_0" GraphRef="n19_REACTOME_179837" RelX="-0.05263157894736842" RelY="-1.2727272727272727"/>
      <Point X="225.0" Y="95.0" GraphId="e_30_i1_1" GraphRef="e_30_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_30_i__0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="336.0" Y="166.0" GraphId="e_30_i__0_0" GraphRef="n67_REACTOME_197745" RelX="-0.015267175572519083" RelY="-1.0769230769230769"/>
      <Point X="336.0" Y="95.0" GraphId="e_30_i__0_1" GraphRef="e_30_a_p" ArrowHead="TBar"/>
    </Graphics>
  </Line>
  <Line GraphId="e_31_REACTOME_182969">
    <Comment Source="WikiPathways-description">EGF (and indeed FGF, PDGF and NGF) stimulation results in CBL phosphorylation on Tyr-371. Phosphorylation is necessary for CBL to exhibit ubiquitin ligase activity.</Comment>
    <BiopaxRef>lit_183081</BiopaxRef>
    <BiopaxRef>lit_183048</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2607.0" Y="444.0" GraphId="e_31_0"/>
      <Point X="2708.0" Y="444.0" GraphId="e_31_1"/>
      <Point X="2752.0" Y="444.0" GraphId="e_31_2"/>
      <Point X="2752.0" Y="313.0" GraphId="e_31_3"/>
      <Point X="2777.0" Y="313.0" GraphId="e_31_4"/>
      <Anchor Position="0.0" GraphId="e_31_a_i"/>
      <Anchor Position="0.33554817275747506" GraphId="e_31_a_p"/>
      <Anchor Position="1.0" GraphId="e_31_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_31_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2521.0" Y="444.0" GraphId="e_31_i0_0" GraphRef="n83_REACTOME_182960" RelX="1.0483870967741935" RelY="0.0"/>
      <Point X="2607.0" Y="444.0" GraphId="e_31_i0_1" GraphRef="e_31_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_31_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2644.0" Y="444.0" GraphId="e_31_i1_0" GraphRef="n586_REACTOME_113592" RelX="-1.1282051282051282" RelY="-0.06666666666666667"/>
      <Point X="2607.0" Y="444.0" GraphId="e_31_i1_1" GraphRef="e_31_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_31_o0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2794.0" Y="313.0" GraphId="e_31_o0_0" ArrowHead="Arrow" GraphRef="n107_REACTOME_182953" RelX="-1.0483870967741935" RelY="-0.04"/>
      <Point X="2777.0" Y="313.0" GraphId="e_31_o0_1" GraphRef="e_31_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_31_o1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2778.0" Y="262.0" GraphId="e_31_o1_0" ArrowHead="Arrow" GraphRef="n587_REACTOME_29370" RelX="-0.05" RelY="1.2"/>
      <Point X="2777.0" Y="313.0" GraphId="e_31_o1_1" GraphRef="e_31_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_31_c__0">
    <Graphics LineStyle="Broken" Color="000000" ConnectorType="Segmented">
      <Point X="2455.0" Y="423.0" GraphId="e_31_c__0_0" GraphRef="n83_REACTOME_182960" RelX="-0.016129032258064516" RelY="-1.1666666666666667"/>
      <Point X="2455.0" Y="380.0" GraphId="e_31_c__0_1"/>
      <Point X="2708.0" Y="380.0" GraphId="e_31_c__0_2"/>
      <Point X="2708.0" Y="444.0" GraphId="e_31_c__0_3" GraphRef="e_31_a_p" ArrowHead="Line"/>
    </Graphics>
  </Line>
  <Line GraphId="e_32_REACTOME_109803">
    <Comment Source="WikiPathways-description">Activated p21ras (the GTP-bound form) is associated with the plasma membrane. Inactive Raf-1 is associated in the cytoplasm with 14-3-3. 14-3-3 binds to Raf-1 via the Ser259 phosphorylation site (S1). This interaction stabilises the inactive conformation of Raf-1 in which the Ras-binding Cysteine-rich domain (CRD) is obscured. The Raf-1 molecule contains an additional p21ras-binding domain (RBD), a second serine phosphorylation site at S621 (S2) and two tyrosine phosphorylation sites (at 340, Y1 and 341, Y2).&lt;br&gt;Raf-1 binds activated p21ras via the RBD. This displaces 14-3-3 from Ser259 and unmasks the CRD.</Comment>
    <BiopaxRef>lit_110028</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="343.0" Y="666.0" GraphId="e_32_0"/>
      <Point X="291.0" Y="666.0" GraphId="e_32_1"/>
      <Point X="243.0" Y="666.0" GraphId="e_32_2"/>
      <Anchor Position="0.0" GraphId="e_32_a_i"/>
      <Anchor Position="0.52" GraphId="e_32_a_p"/>
      <Anchor Position="1.0" GraphId="e_32_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_32_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="377.0" Y="622.0" GraphId="e_32_i0_0" GraphRef="n43_REACTOME_109783" RelX="-0.20930232558139536" RelY="1.2727272727272727"/>
      <Point X="343.0" Y="666.0" GraphId="e_32_i0_1" GraphRef="e_32_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_32_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="361.0" Y="702.0" GraphId="e_32_i1_0" GraphRef="n99_REACTOME_109787" RelX="-0.20634920634920634" RelY="-1.12"/>
      <Point X="343.0" Y="666.0" GraphId="e_32_i1_1" GraphRef="e_32_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_32_o0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="213.0" Y="628.0" GraphId="e_32_o0_0" ArrowHead="Arrow" GraphRef="n12_REACTOME_109788" RelX="0.25" RelY="1.2727272727272727"/>
      <Point X="243.0" Y="666.0" GraphId="e_32_o0_1" GraphRef="e_32_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_32_o1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="215.0" Y="722.0" GraphId="e_32_o1_0" ArrowHead="Arrow" GraphRef="n117_REACTOME_48888" RelX="0.1553398058252427" RelY="-1.1666666666666667"/>
      <Point X="243.0" Y="666.0" GraphId="e_32_o1_1" GraphRef="e_32_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_36_REACTOME_182994">
    <Comment Source="WikiPathways-description">CBl-CIN85-Endophilin complex mediates ligand-induced down-regulation of the EGF receptor. The BAR domain of endophilin induces membrane curvature. The three SH3 domains of CIN85 bind to atypical proline-arginine motifs (PxxxPR) present in the carboxyl termini of CBL and CBL-b. In this way, CIN85 clusters CBL molecules, which is crucial for efficient EGFR endocytosis and degradation.</Comment>
    <BiopaxRef>lit_183056</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2837.0" Y="569.0" GraphId="e_36_0"/>
      <Point X="2837.0" Y="525.0" GraphId="e_36_1"/>
      <Point X="2837.0" Y="493.0" GraphId="e_36_2" GraphRef="n81_REACTOME_182946" RelX="0.0" RelY="1.09375" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_36_a_i"/>
      <Anchor Position="0.5789473684210527" GraphId="e_36_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_36_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2720.0" Y="601.0" GraphId="e_36_i0_0" GraphRef="n129_REACTOME_182948" RelX="0.016129032258064516" RelY="-1.12"/>
      <Point X="2723.0" Y="569.0" GraphId="e_36_i0_1"/>
      <Point X="2837.0" Y="569.0" GraphId="e_36_i0_2" GraphRef="e_36_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_36_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2983.0" Y="725.0" GraphId="e_36_i1_0" GraphRef="n132_REACTOME_182934" RelX="-0.018518518518518517" RelY="-1.2727272727272727"/>
      <Point X="2981.0" Y="569.0" GraphId="e_36_i1_1"/>
      <Point X="2837.0" Y="569.0" GraphId="e_36_i1_2" GraphRef="e_36_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_45_REACTOME_177935">
    <Comment Source="WikiPathways-description">The tyrosine-protein phosphatase SHP2 is a positive effector of EGFR signalling. SHP2 inhibits the tyrosine-dependent translocation of RasGAP (catalyses Ras inactivation) to the plasma membrane, thereby keeping it away from Ras-GTP (its substrate). This inhibition is achieved by the dephosphorylation of a RasGAP binding site on the EGF receptor.</Comment>
    <BiopaxRef>lit_180330</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1686.0" Y="522.0" GraphId="e_45_0"/>
      <Point X="1686.0" Y="501.0" GraphId="e_45_1"/>
      <Point X="1686.0" Y="477.0" GraphId="e_45_2"/>
      <Anchor Position="0.0" GraphId="e_45_a_i"/>
      <Anchor Position="0.4666666666666667" GraphId="e_45_a_p"/>
      <Anchor Position="1.0" GraphId="e_45_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_45_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1706.0" Y="522.0" GraphId="e_45_i0_0" GraphRef="n588_REACTOME_29356" RelX="-1.1428571428571428" RelY="0.0"/>
      <Point X="1686.0" Y="522.0" GraphId="e_45_i0_1" GraphRef="e_45_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_45_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1686.0" Y="544.0" GraphId="e_45_i1_0" GraphRef="n9_REACTOME_180269" RelX="-0.014925373134328358" RelY="-1.09375"/>
      <Point X="1686.0" Y="522.0" GraphId="e_45_i1_1" GraphRef="e_45_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_45_o0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1686.0" Y="452.0" GraphId="e_45_o0_0" ArrowHead="Arrow" GraphRef="n21_REACTOME_180326" RelX="0.0" RelY="1.09375"/>
      <Point X="1686.0" Y="477.0" GraphId="e_45_o0_1" GraphRef="e_45_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_45_o1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1709.0" Y="477.0" GraphId="e_45_o1_0" ArrowHead="Arrow" GraphRef="n589_REACTOME_29372" RelX="-1.0458715596330275" RelY="-0.06666666666666667"/>
      <Point X="1686.0" Y="477.0" GraphId="e_45_o1_1" GraphRef="e_45_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_45_c__0">
    <Graphics LineStyle="Broken" Color="000000" ConnectorType="Segmented">
      <Point X="1649.0" Y="544.0" GraphId="e_45_c__0_0" GraphRef="n9_REACTOME_180269" RelX="-0.5671641791044776" RelY="-1.09375"/>
      <Point X="1625.0" Y="526.0" GraphId="e_45_c__0_1"/>
      <Point X="1625.0" Y="500.0" GraphId="e_45_c__0_2"/>
      <Point X="1686.0" Y="501.0" GraphId="e_45_c__0_3" GraphRef="e_45_a_p" ArrowHead="Line"/>
    </Graphics>
  </Line>
  <Line GraphId="e_47_REACTOME_179467">
    <Comment Source="WikiPathways-description">The pleckstrin homology (PH) domain of GAB1 binds to PIP3 and can target GAB1 to the plasma membrane in response to EGF stimulation. This mechanism provides a positive feedback  loop with respect to PI3K activation, to enhance EGFR signalling.</Comment>
    <BiopaxRef>lit_179899</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1395.0" Y="240.0" GraphId="e_47_0"/>
      <Point X="1364.0" Y="203.0" GraphId="e_47_1"/>
      <Point X="1328.0" Y="159.0" GraphId="e_47_2" GraphRef="n143_REACTOME_180282" RelX="0.2992125984251969" RelY="1.12" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_47_a_i"/>
      <Anchor Position="0.45918689864500606" GraphId="e_47_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_47_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1476.0" Y="190.0" GraphId="e_47_i0_0" GraphRef="n125_REACTOME_179838" RelX="-0.5" RelY="1.1363636363636365"/>
      <Point X="1395.0" Y="240.0" GraphId="e_47_i0_1" GraphRef="e_47_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_47_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1353.0" Y="276.0" GraphId="e_47_i1_0" GraphRef="n106_REACTOME_180348" RelX="0.4642857142857143" RelY="-1.12"/>
      <Point X="1395.0" Y="240.0" GraphId="e_47_i1_1" GraphRef="e_47_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_50_REACTOME_177945">
    <Comment Source="WikiPathways-description">SOS is the guanine nucleotide exchange factor (GEF) for Ras. SOS activates Ras nucleotide exchange from the inactive form (bound to GDP) to an active form (bound to GTP).</Comment>
    <BiopaxRef>lit_179827</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="701.0" Y="659.0" GraphId="e_50_0"/>
      <Point X="599.0" Y="659.0" GraphId="e_50_1"/>
      <Point X="497.0" Y="659.0" GraphId="e_50_2"/>
      <Anchor Position="0.0" GraphId="e_50_a_i"/>
      <Anchor Position="0.5" GraphId="e_50_a_p"/>
      <Anchor Position="1.0" GraphId="e_50_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_50_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="744.0" Y="694.0" GraphId="e_50_i0_0" GraphRef="n85_REACTOME_29438" RelX="-0.85" RelY="-1.2"/>
      <Point X="701.0" Y="659.0" GraphId="e_50_i0_1" GraphRef="e_50_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_50_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="734.0" Y="632.0" GraphId="e_50_i1_0" GraphRef="n115_REACTOME_109796" RelX="-0.2988505747126437" RelY="1.2727272727272727"/>
      <Point X="701.0" Y="659.0" GraphId="e_50_i1_1" GraphRef="e_50_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_50_o0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="409.0" Y="622.0" GraphId="e_50_o0_0" ArrowHead="Arrow" GraphRef="n43_REACTOME_109783" RelX="0.5348837209302325" RelY="1.2727272727272727"/>
      <Point X="497.0" Y="659.0" GraphId="e_50_o0_1" GraphRef="e_50_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_50_o1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="483.0" Y="718.0" GraphId="e_50_o1_0" ArrowHead="Arrow" GraphRef="n25_REACTOME_29420" RelX="0.14634146341463414" RelY="-1.2"/>
      <Point X="497.0" Y="659.0" GraphId="e_50_o1_1" GraphRef="e_50_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_50_c__0">
    <Graphics LineStyle="Broken" Color="000000" ConnectorType="Segmented">
      <Point X="697.0" Y="573.0" GraphId="e_50_c__0_0" GraphRef="n74_REACTOME_180331" RelX="-0.4375" RelY="1.12"/>
      <Point X="599.0" Y="659.0" GraphId="e_50_c__0_1" GraphRef="e_50_a_p" ArrowHead="Line"/>
    </Graphics>
  </Line>
  <Line GraphId="e_51_REACTOME_177923">
    <Comment Source="WikiPathways-description">SHP2 can dephosphorylate paxillin, which leads to Csk dissociation from the paxillin-Src complex and Src activation. Src is an SHP2 effector in EGF-stimulated Erk activation and cell migration.</Comment>
    <BiopaxRef>lit_180518</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1865.0" Y="359.0" GraphId="e_51_0"/>
      <Point X="1884.0" Y="359.0" GraphId="e_51_1"/>
      <Point X="1926.0" Y="359.0" GraphId="e_51_2"/>
      <Anchor Position="0.0" GraphId="e_51_a_i"/>
      <Anchor Position="0.3114754098360656" GraphId="e_51_a_p"/>
      <Anchor Position="1.0" GraphId="e_51_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_51_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1849.0" Y="396.0" GraphId="e_51_i0_0" GraphRef="n590_REACTOME_29356" RelX="0.2857142857142857" RelY="-1.2"/>
      <Point X="1865.0" Y="359.0" GraphId="e_51_i0_1" GraphRef="e_51_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_51_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1846.0" Y="359.0" GraphId="e_51_i1_0" GraphRef="n16_REACTOME_180522" RelX="1.0707070707070707" RelY="0.0"/>
      <Point X="1865.0" Y="359.0" GraphId="e_51_i1_1" GraphRef="e_51_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_51_o0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1977.0" Y="313.0" GraphId="e_51_o0_0" ArrowHead="Arrow" GraphRef="n137_REACTOME_180523" RelX="-0.19672131147540983" RelY="1.2727272727272727"/>
      <Point X="1926.0" Y="359.0" GraphId="e_51_o0_1" GraphRef="e_51_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_51_o1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1876.0" Y="294.0" GraphId="e_51_o1_0" ArrowHead="Arrow" GraphRef="n591_REACTOME_29372" RelX="0.1834862385321101" RelY="1.2"/>
      <Point X="1926.0" Y="359.0" GraphId="e_51_o1_1" GraphRef="e_51_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_51_o2">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1981.0" Y="425.0" GraphId="e_51_o2_0" ArrowHead="Arrow" GraphRef="n122_REACTOME_180499" RelX="-0.27522935779816515" RelY="-1.1666666666666667"/>
      <Point X="1926.0" Y="359.0" GraphId="e_51_o2_1" GraphRef="e_51_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_51_c__0">
    <Graphics LineStyle="Broken" Color="000000" ConnectorType="Segmented">
      <Point X="1747.0" Y="544.0" GraphId="e_51_c__0_0" GraphRef="n9_REACTOME_180269" RelX="0.8955223880597015" RelY="-1.09375"/>
      <Point X="1883.0" Y="476.0" GraphId="e_51_c__0_1"/>
      <Point X="1884.0" Y="359.0" GraphId="e_51_c__0_2" GraphRef="e_51_a_p" ArrowHead="Line"/>
    </Graphics>
  </Line>
  <Line GraphId="e_52_REACTOME_177938">
    <Comment Source="WikiPathways-description">The guanine nucleotide exchange factor SOS interacts with EGFR through the adaptor protein, GRB2. Upon formation of this complex, SOS activates Ras by promoting GDP release and GTP binding.</Comment>
    <BiopaxRef>lit_179827</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="701.0" Y="659.0" GraphId="e_52_0"/>
      <Point X="599.0" Y="659.0" GraphId="e_52_1"/>
      <Point X="497.0" Y="659.0" GraphId="e_52_2"/>
      <Anchor Position="0.0" GraphId="e_52_a_i"/>
      <Anchor Position="0.5" GraphId="e_52_a_p"/>
      <Anchor Position="1.0" GraphId="e_52_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_52_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="744.0" Y="694.0" GraphId="e_52_i0_0" GraphRef="n85_REACTOME_29438" RelX="-0.85" RelY="-1.2"/>
      <Point X="701.0" Y="659.0" GraphId="e_52_i0_1" GraphRef="e_52_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_52_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="734.0" Y="632.0" GraphId="e_52_i1_0" GraphRef="n115_REACTOME_109796" RelX="-0.2988505747126437" RelY="1.2727272727272727"/>
      <Point X="701.0" Y="659.0" GraphId="e_52_i1_1" GraphRef="e_52_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_52_o0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="409.0" Y="622.0" GraphId="e_52_o0_0" ArrowHead="Arrow" GraphRef="n43_REACTOME_109783" RelX="0.5348837209302325" RelY="1.2727272727272727"/>
      <Point X="497.0" Y="659.0" GraphId="e_52_o0_1" GraphRef="e_52_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_52_o1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="483.0" Y="718.0" GraphId="e_52_o1_0" ArrowHead="Arrow" GraphRef="n25_REACTOME_29420" RelX="0.14634146341463414" RelY="-1.2"/>
      <Point X="497.0" Y="659.0" GraphId="e_52_o1_1" GraphRef="e_52_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_52_c__0">
    <Graphics LineStyle="Broken" Color="000000" ConnectorType="Segmented">
      <Point X="596.0" Y="576.0" GraphId="e_52_c__0_0" GraphRef="n33_REACTOME_179820" RelX="0.0" RelY="1.12"/>
      <Point X="599.0" Y="659.0" GraphId="e_52_c__0_1" GraphRef="e_52_a_p" ArrowHead="Line"/>
    </Graphics>
  </Line>
  <Line GraphId="e_53_REACTOME_183051">
    <Comment Source="WikiPathways-description">Sprouty is ubiquitinated by CBL in an EGF-dependent manner. EGF stimulation induces the tyrosine phosphorylation of Sprouty, which in turn enhances the interaction of Sprouty with CBL. The CBL-mediated ubiquitination of Sprouty targets the protein for degradation by the 26S proteasome.</Comment>
    <BiopaxRef>lit_183004</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="3034.0" Y="593.0" GraphId="e_53_0"/>
      <Point X="3035.0" Y="471.0" GraphId="e_53_1"/>
      <Point X="3149.0" Y="471.0" GraphId="e_53_2" GraphRef="n5_REACTOME_182939" RelX="-1.0483870967741935" RelY="0.0" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_53_a_i"/>
      <Anchor Position="0.5169575408854185" GraphId="e_53_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_53_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="3166.0" Y="593.0" GraphId="e_53_i0_0" GraphRef="n142_REACTOME_182935" RelX="-1.0393700787401574" RelY="0.0"/>
      <Point X="3034.0" Y="593.0" GraphId="e_53_i0_1" GraphRef="e_53_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_53_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2846.0" Y="766.0" GraphId="e_53_i1_0" GraphRef="n136_REACTOME_113595" RelX="0.3793103448275862" RelY="-1.2727272727272727"/>
      <Point X="3034.0" Y="593.0" GraphId="e_53_i1_1" GraphRef="e_53_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_53_c__0">
    <Graphics LineStyle="Broken" Color="000000" ConnectorType="Segmented">
      <Point X="2887.0" Y="342.0" GraphId="e_53_c__0_0" GraphRef="n107_REACTOME_182953" RelX="0.45161290322580644" RelY="1.12"/>
      <Point X="3035.0" Y="471.0" GraphId="e_53_c__0_1" GraphRef="e_53_a_p" ArrowHead="Line"/>
    </Graphics>
  </Line>
  <Line GraphId="e_54_REACTOME_183002">
    <Comment Source="WikiPathways-description">High concentrations of active CDC42 and bPix may promote the binding of bPix to CBL, pushing out the usually preferred binding partner CIN85 from the CBL complex. This competitive mechanism could block the CIN85-imposed clustering phenomenon on CBL that is required for tighter binding.</Comment>
    <BiopaxRef>lit_182989</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2452.0" Y="232.0" GraphId="e_54_0"/>
      <Point X="2516.0" Y="232.0" GraphId="e_54_1"/>
      <Point X="2580.0" Y="232.0" GraphId="e_54_2"/>
      <Anchor Position="0.0" GraphId="e_54_a_i"/>
      <Anchor Position="0.5" GraphId="e_54_a_p"/>
      <Anchor Position="1.0" GraphId="e_54_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_54_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2423.0" Y="196.0" GraphId="e_54_i0_0" GraphRef="n39_REACTOME_182917" RelX="0.24074074074074073" RelY="1.1666666666666667"/>
      <Point X="2452.0" Y="232.0" GraphId="e_54_i0_1" GraphRef="e_54_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_54_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2416.0" Y="278.0" GraphId="e_54_i1_0" GraphRef="n101_REACTOME_182943" RelX="0.2903225806451613" RelY="-1.12"/>
      <Point X="2452.0" Y="232.0" GraphId="e_54_i1_1" GraphRef="e_54_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_54_o0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2619.0" Y="255.0" GraphId="e_54_o0_0" ArrowHead="Arrow" GraphRef="n109_REACTOME_182932" RelX="-0.7903225806451613" RelY="-1.09375"/>
      <Point X="2580.0" Y="232.0" GraphId="e_54_o0_1" GraphRef="e_54_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_54_o1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2614.0" Y="192.0" GraphId="e_54_o1_0" ArrowHead="Arrow" GraphRef="n88_REACTOME_182955" RelX="-0.4090909090909091" RelY="1.2727272727272727"/>
      <Point X="2580.0" Y="232.0" GraphId="e_54_o1_1" GraphRef="e_54_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_56_REACTOME_182988">
    <Comment Source="WikiPathways-description">The NEYTEG motif  is very similar to the CBL binding motif around Tyr-1045 in EGFR. Tyrosine-phosphorylated Sprouty (hSpry)  binds to CBL, which then can't ubiquitinate EGFR. Sprouty acts as a decoy to lure CBL away from EGFR and targets it for degradation.</Comment>
    <BiopaxRef>lit_188628</BiopaxRef>
    <BiopaxRef>lit_188630</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1470.0" Y="808.0" GraphId="e_56_0"/>
      <Point X="1528.0" Y="808.0" GraphId="e_56_1"/>
      <Point X="1576.0" Y="808.0" GraphId="e_56_2" GraphRef="n46_REACTOME_182914" RelX="-1.0789473684210527" RelY="0.0" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_56_a_i"/>
      <Anchor Position="0.5471698113207547" GraphId="e_56_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_56_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1439.0" Y="828.0" GraphId="e_56_i0_0" GraphRef="n48_REACTOME_112199" RelX="0.9655172413793104" RelY="-1.2727272727272727"/>
      <Point X="1470.0" Y="808.0" GraphId="e_56_i0_1" GraphRef="e_56_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_56_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1453.0" Y="786.0" GraphId="e_56_i1_0" GraphRef="n102_REACTOME_182950" RelX="0.2391304347826087" RelY="1.1666666666666667"/>
      <Point X="1470.0" Y="808.0" GraphId="e_56_i1_1" GraphRef="e_56_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_58_REACTOME_183052">
    <Comment Source="WikiPathways-description">CBL binds multiple signalling proteins including GRB2. The CBL:GRB2 complex translocates to the plasma membrane where it can bind to GRB2-specific docking sites on the EGF receptor.</Comment>
    <BiopaxRef>lit_183083</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1424.0" Y="916.0" GraphId="e_58_0"/>
      <Point X="1599.0" Y="916.0" GraphId="e_58_1"/>
      <Point X="2169.0" Y="916.0" GraphId="e_58_2"/>
      <Point X="2169.0" Y="732.0" GraphId="e_58_3" GraphRef="n68_REACTOME_182910" RelX="-0.03076923076923077" RelY="1.2727272727272727" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_58_a_i"/>
      <Anchor Position="0.1883745963401507" GraphId="e_58_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_58_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1424.0" Y="856.0" GraphId="e_58_i0_0" GraphRef="n48_REACTOME_112199" RelX="-0.06896551724137931" RelY="1.2727272727272727"/>
      <Point X="1424.0" Y="916.0" GraphId="e_58_i0_1" GraphRef="e_58_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_58_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1079.0" Y="916.0" GraphId="e_58_i1_0" GraphRef="n38_REACTOME_74686" RelX="1.15" RelY="0.0"/>
      <Point X="1424.0" Y="916.0" GraphId="e_58_i1_1" GraphRef="e_58_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_62_REACTOME_183035">
    <Comment Source="WikiPathways-description">The NEYTEG motif  is very similar to the CBL binding motif around Tyr-1045 in EGFR. Tyrosine-phosphorylated Sprouty (hSpry)  binds to CBL, which then can't ubiquitinate EGFR. Sprouty acts as a decoy to lure CBL away from EGFR and targets it for degradation.</Comment>
    <BiopaxRef>lit_188628</BiopaxRef>
    <BiopaxRef>lit_188630</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2199.0" Y="271.0" GraphId="e_62_0"/>
      <Point X="2199.0" Y="225.0" GraphId="e_62_1"/>
      <Point X="2199.0" Y="170.0" GraphId="e_62_2" GraphRef="n114_REACTOME_182938" RelX="0.0" RelY="1.2727272727272727" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_62_a_i"/>
      <Anchor Position="0.45544554455445546" GraphId="e_62_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_62_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2227.0" Y="287.0" GraphId="e_62_i0_0" GraphRef="n100_REACTOME_112192" RelX="-1.1724137931034482" RelY="-0.7272727272727273"/>
      <Point X="2199.0" Y="271.0" GraphId="e_62_i0_1" GraphRef="e_62_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_62_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2171.0" Y="280.0" GraphId="e_62_i1_0" GraphRef="n124_REACTOME_183070" RelX="1.065217391304348" RelY="-0.7777777777777778"/>
      <Point X="2199.0" Y="271.0" GraphId="e_62_i1_1" GraphRef="e_62_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_63_REACTOME_177941">
    <Comment Source="WikiPathways-description">The regulatory subunit of PI3K mediates the association of GAB1 and receptor protein-tyrosine kinases such as the  EGF receptor, which can phosphorylate GAB1. It appears that the PI3K regulatory subunit acts as an adaptor protein allowing GAB1 to serve as a substrate for several tyrosine kinases.</Comment>
    <BiopaxRef>lit_188537</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="544.0" Y="754.0" GraphId="e_63_0"/>
      <Point X="544.0" Y="776.0" GraphId="e_63_1"/>
      <Point X="544.0" Y="814.0" GraphId="e_63_2" GraphRef="n60_REACTOME_179867" RelX="0.0" RelY="-1.1666666666666667" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_63_a_i"/>
      <Anchor Position="0.36666666666666664" GraphId="e_63_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_63_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="594.0" Y="293.0" GraphId="e_63_i0_0" GraphRef="n72_REACTOME_179882" RelX="-1.0483870967741935" RelY="0.0"/>
      <Point X="544.0" Y="293.0" GraphId="e_63_i0_1"/>
      <Point X="544.0" Y="754.0" GraphId="e_63_i0_2" GraphRef="e_63_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_63_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="783.0" Y="750.0" GraphId="e_63_i1_0" GraphRef="n26_REACTOME_179864" RelX="-1.04" RelY="0.0"/>
      <Point X="544.0" Y="754.0" GraphId="e_63_i1_1" GraphRef="e_63_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_70_REACTOME_182990">
    <Comment Source="WikiPathways-description">Sprouty can constitutively interact with two SH3 domains of CIN85 whereas the third SH3 domain of CIN85 can still associate with CBL on cell activation with EGF. This allows Sprouty to block CIN85-mediated clustering of CBL molecules, stablisation of CBL-EGFR interactions and efficient ubiquitination and down-regulation of EGFR.</Comment>
    <BiopaxRef>lit_183032</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="3496.0" Y="369.0" GraphId="e_70_0"/>
      <Point X="3496.0" Y="309.0" GraphId="e_70_1"/>
      <Point X="3496.0" Y="218.0" GraphId="e_70_2" GraphRef="n131_REACTOME_182931" RelX="0.0" RelY="1.0566037735849056" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_70_a_i"/>
      <Anchor Position="0.3973509933774834" GraphId="e_70_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_70_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="3466.0" Y="390.0" GraphId="e_70_i0_0" GraphRef="n120_REACTOME_182961" RelX="1.054263565891473" RelY="-0.9347826086956522"/>
      <Point X="3496.0" Y="369.0" GraphId="e_70_i0_1" GraphRef="e_70_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_70_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="3554.0" Y="418.0" GraphId="e_70_i1_0" GraphRef="n40_REACTOME_182912" RelX="-0.5098039215686274" RelY="-1.2727272727272727"/>
      <Point X="3496.0" Y="369.0" GraphId="e_70_i1_1" GraphRef="e_70_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_75_REACTOME_109813">
    <Comment Source="WikiPathways-description">In the cytoplasm of unstimulated cells, SOS is found in a complex with GRB2. The interaction occurs between  the carboxy terminal domain of SOS and the Src homology 3 (SH3) domains of GRB2.</Comment>
    <BiopaxRef>lit_110024</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="957.0" Y="882.0" GraphId="e_75_0"/>
      <Point X="957.0" Y="807.0" GraphId="e_75_1"/>
      <Point X="957.0" Y="723.0" GraphId="e_75_2" GraphRef="n78_REACTOME_109797" RelX="0.0" RelY="1.2727272727272727" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_75_a_i"/>
      <Anchor Position="0.4716981132075472" GraphId="e_75_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_75_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="915.0" Y="910.0" GraphId="e_75_i0_0" GraphRef="n105_REACTOME_64847" RelX="0.40350877192982454" RelY="-1.1666666666666667"/>
      <Point X="957.0" Y="882.0" GraphId="e_75_i0_1" GraphRef="e_75_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_75_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1033.0" Y="909.0" GraphId="e_75_i1_0" GraphRef="n38_REACTOME_74686" RelX="-1.15" RelY="-0.6363636363636364"/>
      <Point X="957.0" Y="882.0" GraphId="e_75_i1_1" GraphRef="e_75_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_77_REACTOME_183089">
    <Comment Source="WikiPathways-description">Sprouty is ubiquitinated by CBL in an EGF-dependent manner. EGF stimulation induces the tyrosine phosphorylation of Sprouty, which in turn enhances the interaction of Sprouty with CBL.The CBL-mediated ubiquitination of Sprouty targets the protein for degradation by the 26S proteosome.</Comment>
    <BiopaxRef>lit_183004</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="3065.0" Y="579.0" GraphId="e_77_0"/>
      <Point X="3092.0" Y="555.0" GraphId="e_77_1"/>
      <Point X="3167.0" Y="506.0" GraphId="e_77_2" GraphRef="n5_REACTOME_182939" RelX="-0.7580645161290323" RelY="1.09375" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_77_a_i"/>
      <Anchor Position="0.28735979182051946" GraphId="e_77_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_77_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2867.0" Y="779.0" GraphId="e_77_i0_0" GraphRef="n136_REACTOME_113595" RelX="1.103448275862069" RelY="-0.09090909090909091"/>
      <Point X="3065.0" Y="779.0" GraphId="e_77_i0_1"/>
      <Point X="3065.0" Y="579.0" GraphId="e_77_i0_2" GraphRef="e_77_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_77_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2878.0" Y="342.0" GraphId="e_77_i1_0" GraphRef="n107_REACTOME_182953" RelX="0.3064516129032258" RelY="1.12"/>
      <Point X="3065.0" Y="579.0" GraphId="e_77_i1_1" GraphRef="e_77_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_77_i2">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="3028.0" Y="679.0" GraphId="e_77_i2_0" GraphRef="n42_REACTOME_182909" RelX="0.11764705882352941" RelY="-1.2727272727272727"/>
      <Point X="3065.0" Y="579.0" GraphId="e_77_i2_1" GraphRef="e_77_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_77_c__0">
    <Graphics LineStyle="Broken" Color="000000" ConnectorType="Segmented">
      <Point X="2883.0" Y="342.0" GraphId="e_77_c__0_0" GraphRef="n107_REACTOME_182953" RelX="0.3870967741935484" RelY="1.12"/>
      <Point X="3092.0" Y="555.0" GraphId="e_77_c__0_1" GraphRef="e_77_a_p" ArrowHead="Line"/>
    </Graphics>
  </Line>
  <Line GraphId="e_79_REACTOME_177934">
    <Comment Source="WikiPathways-description">The cytoplasmic domain of EGFR contains tyrosine, serine and threonine phosphorylation sites. Dimerization of EGFR activates its intrinsic protein kinase activity and results in autophosphorylation of 5 of these sites (Y992, Y1068, Y1086, Y1148 and Y1173). Tyrosine autophosphorylation is crucial for normal receptor signalling as it provides specific binding sites for cytosolic target proteins involved in signal transmission.</Comment>
    <BiopaxRef>lit_179793</BiopaxRef>
    <BiopaxRef>lit_189933</BiopaxRef>
    <BiopaxRef>lit_189936</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="661.0" Y="156.0" GraphId="e_79_0"/>
      <Point X="674.0" Y="195.0" GraphId="e_79_1"/>
      <Point X="668.0" Y="223.0" GraphId="e_79_2"/>
      <Anchor Position="0.0" GraphId="e_79_a_i"/>
      <Anchor Position="0.5894252092438343" GraphId="e_79_a_p"/>
      <Anchor Position="1.0" GraphId="e_79_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_79_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="693.0" Y="146.0" GraphId="e_79_i0_0" GraphRef="n592_REACTOME_113592" RelX="-1.1282051282051282" RelY="0.3333333333333333"/>
      <Point X="661.0" Y="156.0" GraphId="e_79_i0_1" GraphRef="e_79_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_79_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="647.0" Y="110.0" GraphId="e_79_i1_0" GraphRef="n4_REACTOME_179845" RelX="0.058823529411764705" RelY="1.2727272727272727"/>
      <Point X="661.0" Y="156.0" GraphId="e_79_i1_1" GraphRef="e_79_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_79_o0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="663.0" Y="258.0" GraphId="e_79_o0_0" ArrowHead="Arrow" GraphRef="n72_REACTOME_179882" RelX="0.06451612903225806" RelY="-1.09375"/>
      <Point X="668.0" Y="223.0" GraphId="e_79_o0_1" GraphRef="e_79_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_79_o1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="708.0" Y="229.0" GraphId="e_79_o1_0" ArrowHead="Arrow" GraphRef="n593_REACTOME_29370" RelX="-1.15" RelY="-0.26666666666666666"/>
      <Point X="668.0" Y="223.0" GraphId="e_79_o1_1" GraphRef="e_79_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_79_c__0">
    <Graphics LineStyle="Broken" Color="000000" ConnectorType="Segmented">
      <Point X="698.0" Y="95.0" GraphId="e_79_c__0_0" GraphRef="n4_REACTOME_179845" RelX="1.0588235294117647" RelY="-0.09090909090909091"/>
      <Point X="738.0" Y="95.0" GraphId="e_79_c__0_1"/>
      <Point X="738.0" Y="194.0" GraphId="e_79_c__0_2"/>
      <Point X="674.0" Y="195.0" GraphId="e_79_c__0_3" GraphRef="e_79_a_p" ArrowHead="Line"/>
    </Graphics>
  </Line>
  <Line GraphId="e_84_REACTOME_183058">
    <Comment Source="WikiPathways-description">EGF (and indeed FGF, PDGF and NGF) stimulation results in CBL phosphorylation on Tyr-371. Phosphorylation is necessary for CBL to exhibit ubiquitin ligase activity.</Comment>
    <BiopaxRef>lit_183081</BiopaxRef>
    <BiopaxRef>lit_183048</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2480.0" Y="627.0" GraphId="e_84_0"/>
      <Point X="2527.0" Y="628.0" GraphId="e_84_1"/>
      <Point X="2590.0" Y="628.0" GraphId="e_84_2"/>
      <Anchor Position="0.0" GraphId="e_84_a_i"/>
      <Anchor Position="0.4273281051352336" GraphId="e_84_a_p"/>
      <Anchor Position="1.0" GraphId="e_84_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_84_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2432.0" Y="626.0" GraphId="e_84_i0_0" GraphRef="n87_REACTOME_182928" RelX="1.0483870967741935" RelY="0.04"/>
      <Point X="2480.0" Y="627.0" GraphId="e_84_i0_1" GraphRef="e_84_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_84_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2479.0" Y="580.0" GraphId="e_84_i1_0" GraphRef="n594_REACTOME_113592" RelX="0.0" RelY="1.2"/>
      <Point X="2480.0" Y="627.0" GraphId="e_84_i1_1" GraphRef="e_84_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_84_o0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2654.0" Y="628.0" GraphId="e_84_o0_0" ArrowHead="Arrow" GraphRef="n129_REACTOME_182948" RelX="-1.0483870967741935" RelY="-0.04"/>
      <Point X="2590.0" Y="628.0" GraphId="e_84_o0_1" GraphRef="e_84_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_84_o1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2589.0" Y="597.0" GraphId="e_84_o1_0" ArrowHead="Arrow" GraphRef="n595_REACTOME_29370" RelX="0.0" RelY="1.2"/>
      <Point X="2590.0" Y="628.0" GraphId="e_84_o1_1" GraphRef="e_84_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_84_c__0">
    <Graphics LineStyle="Broken" Color="000000" ConnectorType="Segmented">
      <Point X="2366.0" Y="597.0" GraphId="e_84_c__0_0" GraphRef="n87_REACTOME_182928" RelX="-0.016129032258064516" RelY="-1.12"/>
      <Point X="2366.0" Y="586.0" GraphId="e_84_c__0_1"/>
      <Point X="2526.0" Y="586.0" GraphId="e_84_c__0_2"/>
      <Point X="2527.0" Y="628.0" GraphId="e_84_c__0_3" GraphRef="e_84_a_p" ArrowHead="Line"/>
    </Graphics>
  </Line>
  <Line GraphId="e_89_REACTOME_177936">
    <Comment Source="WikiPathways-description">The tyrosine sites on SHC become possible binding sites for the GRB2:SOS complex.</Comment>
    <BiopaxRef>lit_179827</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="954.0" Y="534.0" GraphId="e_89_0"/>
      <Point X="852.0" Y="534.0" GraphId="e_89_1"/>
      <Point X="792.0" Y="539.0" GraphId="e_89_2" GraphRef="n74_REACTOME_180331" RelX="1.046875" RelY="-0.24" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_89_a_i"/>
      <Anchor Position="0.6288223579902537" GraphId="e_89_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_89_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="982.0" Y="535.0" GraphId="e_89_i0_0" GraphRef="n112_REACTOME_180337" RelX="-1.0483870967741935" RelY="-0.16666666666666666"/>
      <Point X="954.0" Y="534.0" GraphId="e_89_i0_1" GraphRef="e_89_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_89_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="956.0" Y="695.0" GraphId="e_89_i1_0" GraphRef="n78_REACTOME_109797" RelX="-0.03076923076923077" RelY="-1.2727272727272727"/>
      <Point X="954.0" Y="534.0" GraphId="e_89_i1_1" GraphRef="e_89_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_92_REACTOME_177943">
    <Comment Source="WikiPathways-description">Cytoplasmic target proteins containing the SH2 domain can bind to activated EGFR. One such protein, growth factor receptor-bound protein 2 (GRB2), can bind activated EGFR with its SH2 domain whilst in complex with SOS through its SH3 domain. GRB2 can bind at either Y1068 and/or Y1086 tyrosine autophosphorylation sites on the receptor.</Comment>
    <BiopaxRef>lit_179801</BiopaxRef>
    <BiopaxRef>lit_179887</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="659.0" Y="441.0" GraphId="e_92_0"/>
      <Point X="599.0" Y="440.0" GraphId="e_92_1"/>
      <Point X="596.0" Y="520.0" GraphId="e_92_2" GraphRef="n33_REACTOME_179820" RelX="0.0" RelY="-1.12" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_92_a_i"/>
      <Anchor Position="0.4284333700996041" GraphId="e_92_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_92_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="659.0" Y="328.0" GraphId="e_92_i0_0" GraphRef="n72_REACTOME_179882" RelX="0.0" RelY="1.09375"/>
      <Point X="659.0" Y="441.0" GraphId="e_92_i0_1" GraphRef="e_92_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_92_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="922.0" Y="709.0" GraphId="e_92_i1_0" GraphRef="n78_REACTOME_109797" RelX="-1.0769230769230769" RelY="0.0"/>
      <Point X="829.0" Y="709.0" GraphId="e_92_i1_1"/>
      <Point X="829.0" Y="441.0" GraphId="e_92_i1_2"/>
      <Point X="659.0" Y="441.0" GraphId="e_92_i1_3" GraphRef="e_92_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_94_REACTOME_183077">
    <Comment Source="WikiPathways-description">Epsin directly modifies membrane curvature on binding to PIP2 in conjunction with clathrin polymerisation.</Comment>
    <BiopaxRef>lit_183075</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="3065.0" Y="276.0" GraphId="e_94_0"/>
      <Point X="3175.0" Y="276.0" GraphId="e_94_1"/>
      <Point X="3265.0" Y="276.0" GraphId="e_94_2" GraphRef="n80_REACTOME_182941" RelX="-1.037593984962406" RelY="-0.021739130434782608" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_94_a_i"/>
      <Anchor Position="0.55" GraphId="e_94_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_94_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2877.0" Y="423.0" GraphId="e_94_i0_0" GraphRef="n81_REACTOME_182946" RelX="0.64" RelY="-1.09375"/>
      <Point X="3065.0" Y="276.0" GraphId="e_94_i0_1" GraphRef="e_94_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_94_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="3121.0" Y="243.0" GraphId="e_94_i1_0" GraphRef="n44_REACTOME_177480" RelX="-0.4827586206896552" RelY="1.1666666666666667"/>
      <Point X="3065.0" Y="276.0" GraphId="e_94_i1_1" GraphRef="e_94_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_94_i2">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="3074.0" Y="344.0" GraphId="e_94_i2_0" GraphRef="n76_REACTOME_182952" RelX="-0.10256410256410256" RelY="-1.2727272727272727"/>
      <Point X="3065.0" Y="276.0" GraphId="e_94_i2_1" GraphRef="e_94_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_94_i3">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="3065.0" Y="178.0" GraphId="e_94_i3_0" GraphRef="n61_REACTOME_177482" RelX="-0.038461538461538464" RelY="1.2727272727272727"/>
      <Point X="3065.0" Y="276.0" GraphId="e_94_i3_1" GraphRef="e_94_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_94_i4">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="3025.0" Y="345.0" GraphId="e_94_i4_0" GraphRef="n23_REACTOME_182937" RelX="0.18867924528301888" RelY="-1.2727272727272727"/>
      <Point X="3065.0" Y="276.0" GraphId="e_94_i4_1" GraphRef="e_94_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_94_i5">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="3151.0" Y="713.0" GraphId="e_94_i5_0" GraphRef="n108_REACTOME_182947" RelX="-0.03669724770642202" RelY="-1.2727272727272727"/>
      <Point X="3110.0" Y="298.0" GraphId="e_94_i5_1"/>
      <Point X="3065.0" Y="276.0" GraphId="e_94_i5_2" GraphRef="e_94_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_94_i6">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="3025.0" Y="257.0" GraphId="e_94_i6_0" GraphRef="n581_REACTOME_179856" RelX="0.5882352941176471" RelY="1.1363636363636365"/>
      <Point X="3065.0" Y="276.0" GraphId="e_94_i6_1" GraphRef="e_94_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_98_REACTOME_183084">
    <Comment Source="WikiPathways-description">BetaPix/Cool-1 associates with CBL, which appears to be a critical step in Cdc42-mediated inhibition of EGFR ubiquitylation and downregulation. The SH3 domain of betaPix specifically interacts with a proline-arginine motif (PxxxPR) present within CBL, which mediates ubiquitylation and subsequent degradation of betaPix.</Comment>
    <BiopaxRef>lit_182989</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2641.0" Y="559.0" GraphId="e_98_0"/>
      <Point X="2579.0" Y="559.0" GraphId="e_98_1"/>
      <Point X="2517.0" Y="559.0" GraphId="e_98_2"/>
      <Anchor Position="0.0" GraphId="e_98_a_i"/>
      <Anchor Position="0.5" GraphId="e_98_a_p"/>
      <Anchor Position="1.0" GraphId="e_98_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_98_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2664.0" Y="325.0" GraphId="e_98_i0_0" GraphRef="n109_REACTOME_182932" RelX="-0.06451612903225806" RelY="1.09375"/>
      <Point X="2641.0" Y="559.0" GraphId="e_98_i0_1" GraphRef="e_98_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_98_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2803.0" Y="779.0" GraphId="e_98_i1_0" GraphRef="n136_REACTOME_113595" RelX="-1.103448275862069" RelY="-0.09090909090909091"/>
      <Point X="2641.0" Y="779.0" GraphId="e_98_i1_1"/>
      <Point X="2641.0" Y="559.0" GraphId="e_98_i1_2" GraphRef="e_98_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_98_o0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2465.0" Y="465.0" GraphId="e_98_o0_0" ArrowHead="Arrow" GraphRef="n83_REACTOME_182960" RelX="0.14516129032258066" RelY="1.1666666666666667"/>
      <Point X="2517.0" Y="559.0" GraphId="e_98_o0_1" GraphRef="e_98_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_98_o1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2482.0" Y="699.0" GraphId="e_98_o1_0" ArrowHead="Arrow" GraphRef="n35_REACTOME_182915" RelX="0.11235955056179775" RelY="-1.12"/>
      <Point X="2517.0" Y="559.0" GraphId="e_98_o1_1" GraphRef="e_98_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_98_c__0">
    <Graphics LineStyle="Broken" Color="000000" ConnectorType="Segmented">
      <Point X="2603.0" Y="290.0" GraphId="e_98_c__0_0" GraphRef="n109_REACTOME_182932" RelX="-1.0483870967741935" RelY="0.0"/>
      <Point X="2578.0" Y="291.0" GraphId="e_98_c__0_1"/>
      <Point X="2579.0" Y="559.0" GraphId="e_98_c__0_2" GraphRef="e_98_a_p" ArrowHead="Line"/>
    </Graphics>
  </Line>
  <Line GraphId="e_104_REACTOME_183055">
    <Comment Source="WikiPathways-description">Phosphorylation at Tyrosine 1045 of EGFR creates a major docking site for E3 ubiquitin-protein ligase, CBL (Casitas B-lineage lymphoma proto- oncogene) and  is required to sort the EGFR to lysosomes for degradation. The E3 ligase Cbl plays a crucial role in these events as it dually participates in early events of internalization via a CIN85-endophilin dependent mechanism and endocytic sorting by mediating multiple monoubiquitylation of the receptor.&lt;br&gt;</Comment>
    <BiopaxRef>lit_183045</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2278.0" Y="444.0" GraphId="e_104_0"/>
      <Point X="2325.0" Y="444.0" GraphId="e_104_1"/>
      <Point X="2371.0" Y="444.0" GraphId="e_104_2"/>
      <Point X="2391.0" Y="444.0" GraphId="e_104_3" GraphRef="n83_REACTOME_182960" RelX="-1.0483870967741935" RelY="0.0" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_104_a_i"/>
      <Anchor Position="0.415929203539823" GraphId="e_104_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_104_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2246.0" Y="309.0" GraphId="e_104_i0_0" GraphRef="n100_REACTOME_112192" RelX="0.13793103448275862" RelY="1.2727272727272727"/>
      <Point X="2278.0" Y="444.0" GraphId="e_104_i0_1" GraphRef="e_104_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_104_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2193.0" Y="516.0" GraphId="e_104_i1_0" GraphRef="n41_REACTOME_182911" RelX="0.3225806451612903" RelY="-1.1666666666666667"/>
      <Point X="2278.0" Y="444.0" GraphId="e_104_i1_1" GraphRef="e_104_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_110_REACTOME_177926">
    <Comment Source="WikiPathways-description">Dephosphorylation of CBP/PAG negatively regulates the recruitment of the Src inhibiting kinase, Csk. Src is not negatively regulated by phosphorylation by Csk.</Comment>
    <BiopaxRef>lit_180502</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1550.0" Y="351.0" GraphId="e_110_0"/>
      <Point X="1575.0" Y="351.0" GraphId="e_110_1"/>
      <Point X="1595.0" Y="351.0" GraphId="e_110_2"/>
      <Anchor Position="0.0" GraphId="e_110_a_i"/>
      <Anchor Position="0.5555555555555556" GraphId="e_110_a_p"/>
      <Anchor Position="1.0" GraphId="e_110_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_110_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1524.0" Y="369.0" GraphId="e_110_i0_0" GraphRef="n596_REACTOME_29356" RelX="0.8571428571428571" RelY="-1.2"/>
      <Point X="1550.0" Y="351.0" GraphId="e_110_i0_1" GraphRef="e_110_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_110_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1527.0" Y="333.0" GraphId="e_110_i1_0" GraphRef="n27_REACTOME_180494" RelX="0.4827586206896552" RelY="1.2413793103448276"/>
      <Point X="1550.0" Y="351.0" GraphId="e_110_i1_1" GraphRef="e_110_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_110_o0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1616.0" Y="351.0" GraphId="e_110_o0_0" ArrowHead="Arrow" GraphRef="n8_REACTOME_180500" RelX="-1.15" RelY="-0.09090909090909091"/>
      <Point X="1595.0" Y="351.0" GraphId="e_110_o0_1" GraphRef="e_110_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_110_o1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1591.0" Y="302.0" GraphId="e_110_o1_0" ArrowHead="Arrow" GraphRef="n597_REACTOME_29372" RelX="0.0" RelY="1.2"/>
      <Point X="1595.0" Y="351.0" GraphId="e_110_o1_1" GraphRef="e_110_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_110_c__0">
    <Graphics LineStyle="Broken" Color="000000" ConnectorType="Segmented">
      <Point X="1625.0" Y="544.0" GraphId="e_110_c__0_0" GraphRef="n9_REACTOME_180269" RelX="-0.9253731343283582" RelY="-1.09375"/>
      <Point X="1575.0" Y="521.0" GraphId="e_110_c__0_1"/>
      <Point X="1575.0" Y="351.0" GraphId="e_110_c__0_2" GraphRef="e_110_a_p" ArrowHead="Line"/>
    </Graphics>
  </Line>
  <Line GraphId="e_111_REACTOME_177944">
    <Comment Source="WikiPathways-description">The SH2 domains repress phosphatase activity of SHP2. Binding of these domains to phosphotyrosine-containing proteins relieves this autoinhibition, possibly by inducing a conformational change in the enzyme.</Comment>
    <BiopaxRef>lit_180288</BiopaxRef>
    <BiopaxRef>lit_180316</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1511.0" Y="567.0" GraphId="e_111_0"/>
      <Point X="1574.0" Y="567.0" GraphId="e_111_1"/>
      <Point X="1617.0" Y="571.0" GraphId="e_111_2" GraphRef="n9_REACTOME_180269" RelX="-1.044776119402985" RelY="-0.25" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_111_a_i"/>
      <Anchor Position="0.5933005308494119" GraphId="e_111_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_111_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1500.0" Y="539.0" GraphId="e_111_i0_0" GraphRef="n127_REACTOME_180286" RelX="0.20408163265306123" RelY="1.09375"/>
      <Point X="1511.0" Y="567.0" GraphId="e_111_i0_1" GraphRef="e_111_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_111_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1500.0" Y="689.0" GraphId="e_111_i1_0" GraphRef="n55_REACTOME_162563" RelX="0.0" RelY="-1.2727272727272727"/>
      <Point X="1511.0" Y="567.0" GraphId="e_111_i1_1" GraphRef="e_111_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_113_REACTOME_183072">
    <Comment Source="WikiPathways-description">At higher concentrations of ligand, a substantial fraction of the receptor (&gt;50%) is endocytosed through a clathrin-dependent, lipid-raft-dependent route as the receptor becomes ubiquitnated and Y1045 phosphorylated. Eps15 and Epsin are found in caveolae. Eps15 and Epsin are immunoprecipated with the EGF receptor.&lt;br&gt;Non-clathrin internalisation of ubiquitinated EGFR depends on its interaction with proteins harbouring the UIM Ub-interacting motif, as shown through the ablation of three Ub-interactingmotif-containing proteins, Eps15, Eps15R and Epsin.</Comment>
    <BiopaxRef>lit_183021</BiopaxRef>
    <BiopaxRef>lit_183040</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="3072.0" Y="430.0" GraphId="e_113_0"/>
      <Point X="3230.0" Y="430.0" GraphId="e_113_1"/>
      <Point X="3331.0" Y="431.0" GraphId="e_113_2" GraphRef="n120_REACTOME_182961" RelX="-1.0387596899224807" RelY="-0.043478260869565216" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_113_a_i"/>
      <Anchor Position="0.6100269503421213" GraphId="e_113_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_113_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="3041.0" Y="739.0" GraphId="e_113_i0_0" GraphRef="n132_REACTOME_182934" RelX="1.0555555555555556" RelY="0.0"/>
      <Point X="3077.0" Y="739.0" GraphId="e_113_i0_1"/>
      <Point X="3072.0" Y="430.0" GraphId="e_113_i0_2" GraphRef="e_113_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_113_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="3075.0" Y="372.0" GraphId="e_113_i1_0" GraphRef="n76_REACTOME_182952" RelX="-0.05128205128205128" RelY="1.2727272727272727"/>
      <Point X="3072.0" Y="430.0" GraphId="e_113_i1_1" GraphRef="e_113_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_113_i2">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="3028.0" Y="373.0" GraphId="e_113_i2_0" GraphRef="n23_REACTOME_182937" RelX="0.3018867924528302" RelY="1.2727272727272727"/>
      <Point X="3072.0" Y="430.0" GraphId="e_113_i2_1" GraphRef="e_113_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_113_i3">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2904.0" Y="342.0" GraphId="e_113_i3_0" GraphRef="n107_REACTOME_182953" RelX="0.7258064516129032" RelY="1.12"/>
      <Point X="3072.0" Y="430.0" GraphId="e_113_i3_1" GraphRef="e_113_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_113_i4">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="3150.0" Y="713.0" GraphId="e_113_i4_0" GraphRef="n108_REACTOME_182947" RelX="-0.05504587155963303" RelY="-1.2727272727272727"/>
      <Point X="3072.0" Y="430.0" GraphId="e_113_i4_1" GraphRef="e_113_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_116_REACTOME_182993">
    <Comment Source="WikiPathways-description">CBL down-regulates receptor tyrosine kinases by conjugating ubiquitin to them. This leads to receptor internalization and degradation. The ubiquitin protein ligase activity of CBL (abbreviated as E3 activity) is mediated by its RING finger domain.</Comment>
    <BiopaxRef>lit_183078</BiopaxRef>
    <BiopaxRef>lit_182974</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2966.0" Y="303.0" GraphId="e_116_0"/>
      <Point X="2898.0" Y="238.0" GraphId="e_116_1"/>
      <Point X="2898.0" Y="190.0" GraphId="e_116_2" GraphRef="n66_REACTOME_182930" RelX="-0.016129032258064516" RelY="1.09375" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_116_a_i"/>
      <Anchor Position="0.6621362980892798" GraphId="e_116_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_116_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2852.0" Y="766.0" GraphId="e_116_i0_0" GraphRef="n136_REACTOME_113595" RelX="0.5862068965517241" RelY="-1.2727272727272727"/>
      <Point X="2965.0" Y="698.0" GraphId="e_116_i0_1"/>
      <Point X="2966.0" Y="303.0" GraphId="e_116_i0_2" GraphRef="e_116_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_116_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="2924.0" Y="307.0" GraphId="e_116_i1_0" GraphRef="n107_REACTOME_182953" RelX="1.0483870967741935" RelY="-0.28"/>
      <Point X="2966.0" Y="303.0" GraphId="e_116_i1_1" GraphRef="e_116_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_116_c__0">
    <Graphics LineStyle="Broken" Color="000000" ConnectorType="Segmented">
      <Point X="2871.0" Y="286.0" GraphId="e_116_c__0_0" GraphRef="n107_REACTOME_182953" RelX="0.1935483870967742" RelY="-1.12"/>
      <Point X="2898.0" Y="238.0" GraphId="e_116_c__0_1" GraphRef="e_116_a_p" ArrowHead="Line"/>
    </Graphics>
  </Line>
  <Line GraphId="e_119_REACTOME_177931">
    <Comment Source="WikiPathways-description">The Src homology 2 (SH2) domain of the phosphatidylinositol 3-kinase (PI3K) regulatory subunit (PI3Kp85) binds to GAB1 in a phosphorylation-independent manner. GAB1 serves as a docking protein which recruits a number of downstream signalling proteins. PI3Kp85 can bind to either GAB1 or phosphorylated GAB1.</Comment>
    <BiopaxRef>lit_179884</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1073.0" Y="750.0" GraphId="e_119_0"/>
      <Point X="1014.0" Y="750.0" GraphId="e_119_1"/>
      <Point X="914.0" Y="750.0" GraphId="e_119_2" GraphRef="n26_REACTOME_179864" RelX="1.056" RelY="0.0" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_119_a_i"/>
      <Anchor Position="0.3710691823899371" GraphId="e_119_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_119_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1073.0" Y="706.0" GraphId="e_119_i0_0" GraphRef="n14_REACTOME_74789" RelX="0.0" RelY="1.2727272727272727"/>
      <Point X="1073.0" Y="750.0" GraphId="e_119_i0_1" GraphRef="e_119_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_119_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1273.0" Y="750.0" GraphId="e_119_i1_0" GraphRef="n69_REACTOME_179849" RelX="-1.0789473684210527" RelY="0.0"/>
      <Point X="1073.0" Y="750.0" GraphId="e_119_i1_1" GraphRef="e_119_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_121_REACTOME_177922">
    <Comment Source="WikiPathways-description">EGF and other growth factors induce oligomerization of their specific receptors. Inactive EGFR monomers are in equilibrium with active EGFR dimers and binding of the EGF ligand stabilizes the active dimeric form.</Comment>
    <BiopaxRef>lit_188642</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="507.0" Y="96.0" GraphId="e_121_0" GraphRef="n20_REACTOME_179847" RelX="1.09375" RelY="0.0"/>
      <Point X="558.0" Y="96.0" GraphId="e_121_1"/>
      <Point X="590.0" Y="96.0" GraphId="e_121_2" GraphRef="n4_REACTOME_179845" RelX="-1.0588235294117647" RelY="0.0" ArrowHead="Arrow"/>
      <Anchor Position="0.6144578313253012" GraphId="e_121_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_123_REACTOME_177925">
    <Comment Source="WikiPathways-description">SHC (Src homology 2 domain-containing) transforming protein can bind to either tyrosine 1148 and/or tyrosine 1173 sites on the EGF receptor.</Comment>
    <BiopaxRef>lit_180339</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="921.0" Y="358.0" GraphId="e_123_0"/>
      <Point X="921.0" Y="428.0" GraphId="e_123_1"/>
      <Point X="1093.0" Y="436.0" GraphId="e_123_2" GraphRef="n90_REACTOME_180301" RelX="-1.0393700787401574" RelY="-0.16666666666666666" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_123_a_i"/>
      <Anchor Position="0.28903411265626694" GraphId="e_123_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_123_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1235.0" Y="688.0" GraphId="e_123_i0_0" GraphRef="n64_REACTOME_74680" RelX="-0.05128205128205128" RelY="-1.2727272727272727"/>
      <Point X="1230.0" Y="398.0" GraphId="e_123_i0_1"/>
      <Point X="921.0" Y="358.0" GraphId="e_123_i0_2" GraphRef="e_123_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_123_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="686.0" Y="328.0" GraphId="e_123_i1_0" GraphRef="n72_REACTOME_179882" RelX="0.43548387096774194" RelY="1.09375"/>
      <Point X="715.0" Y="358.0" GraphId="e_123_i1_1"/>
      <Point X="921.0" Y="358.0" GraphId="e_123_i1_2" GraphRef="e_123_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_126_REACTOME_177930">
    <Comment Source="WikiPathways-description">EGFR kinase phosphorylates the phosphorylation sites tyrosine 627 and 659 on GAB1</Comment>
    <BiopaxRef>lit_180279</BiopaxRef>
    <BiopaxRef>lit_180324</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1327.0" Y="418.0" GraphId="e_126_0"/>
      <Point X="1327.0" Y="504.0" GraphId="e_126_1"/>
      <Point X="1402.0" Y="504.0" GraphId="e_126_2"/>
      <Point X="1420.0" Y="504.0" GraphId="e_126_3"/>
      <Anchor Position="0.0" GraphId="e_126_a_i"/>
      <Anchor Position="0.8994413407821229" GraphId="e_126_a_p"/>
      <Anchor Position="1.0" GraphId="e_126_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_126_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1327.0" Y="332.0" GraphId="e_126_i0_0" GraphRef="n106_REACTOME_180348" RelX="0.0" RelY="1.12"/>
      <Point X="1327.0" Y="418.0" GraphId="e_126_i0_1" GraphRef="e_126_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_126_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1356.0" Y="418.0" GraphId="e_126_i1_0" GraphRef="n598_REACTOME_113592" RelX="-1.1282051282051282" RelY="-0.06666666666666667"/>
      <Point X="1327.0" Y="418.0" GraphId="e_126_i1_1" GraphRef="e_126_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_126_o0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1420.0" Y="540.0" GraphId="e_126_o0_0" ArrowHead="Arrow" GraphRef="n599_REACTOME_29370" RelX="-0.05" RelY="-1.2"/>
      <Point X="1420.0" Y="504.0" GraphId="e_126_o0_1" GraphRef="e_126_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_126_o1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1438.0" Y="504.0" GraphId="e_126_o1_0" ArrowHead="Arrow" GraphRef="n127_REACTOME_180286" RelX="-1.0612244897959184" RelY="0.0"/>
      <Point X="1420.0" Y="504.0" GraphId="e_126_o1_1" GraphRef="e_126_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_126_c__0">
    <Graphics LineStyle="Broken" Color="000000" ConnectorType="Segmented">
      <Point X="1386.0" Y="304.0" GraphId="e_126_c__0_0" GraphRef="n106_REACTOME_180348" RelX="1.0535714285714286" RelY="0.0"/>
      <Point X="1401.0" Y="304.0" GraphId="e_126_c__0_1"/>
      <Point X="1402.0" Y="504.0" GraphId="e_126_c__0_2" GraphRef="e_126_a_p" ArrowHead="Line"/>
    </Graphics>
  </Line>
  <Line GraphId="e_135_REACTOME_177937">
    <Comment Source="WikiPathways-description">As well as autophosphorylation, EGFR can become tyrosine-phosphorylated by the action of  the proto-oncogene tyrosine-protein kinase, c-src. This Src homology 2 (SH2) domain-containing protein is one of many such proteins which bind to phosphorylated sites on EGFR to effect signal transmission into the cell.</Comment>
    <BiopaxRef>lit_179802</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="632.0" Y="157.0" GraphId="e_135_0"/>
      <Point X="624.0" Y="197.0" GraphId="e_135_1"/>
      <Point X="633.0" Y="224.0" GraphId="e_135_2"/>
      <Anchor Position="0.0" GraphId="e_135_a_i"/>
      <Anchor Position="0.5890338223009471" GraphId="e_135_a_p"/>
      <Anchor Position="1.0" GraphId="e_135_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_135_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="598.0" Y="154.0" GraphId="e_135_i0_0" GraphRef="n600_REACTOME_113592" RelX="1.1794871794871795" RelY="0.06666666666666667"/>
      <Point X="632.0" Y="157.0" GraphId="e_135_i0_1" GraphRef="e_135_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_135_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="641.0" Y="110.0" GraphId="e_135_i1_0" GraphRef="n4_REACTOME_179845" RelX="-0.058823529411764705" RelY="1.2727272727272727"/>
      <Point X="632.0" Y="157.0" GraphId="e_135_i1_1" GraphRef="e_135_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_135_o0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="646.0" Y="258.0" GraphId="e_135_o0_0" ArrowHead="Arrow" GraphRef="n72_REACTOME_179882" RelX="-0.20967741935483872" RelY="-1.09375"/>
      <Point X="633.0" Y="224.0" GraphId="e_135_o0_1" GraphRef="e_135_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_135_o1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="586.0" Y="234.0" GraphId="e_135_o1_0" ArrowHead="Arrow" GraphRef="n601_REACTOME_29370" RelX="1.15" RelY="-0.26666666666666666"/>
      <Point X="633.0" Y="224.0" GraphId="e_135_o1_1" GraphRef="e_135_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_135_c__0">
    <Graphics LineStyle="Broken" Color="000000" ConnectorType="Segmented">
      <Point X="557.0" Y="198.0" GraphId="e_135_c__0_0" GraphRef="n118_REACTOME_65043" RelX="1.2" RelY="-0.09090909090909091"/>
      <Point X="624.0" Y="197.0" GraphId="e_135_c__0_1" GraphRef="e_135_a_p" ArrowHead="Line"/>
    </Graphics>
  </Line>
  <Line GraphId="e_138_REACTOME_177924">
    <Comment Source="WikiPathways-description">Phosphorylated GAB1 can bind PI3 kinase by its regulatory alpha subunit. SHP2 dephosphorylation of the tyrosine residues 447, 472 and 589 on GAB1 means PI3 kinase can no longer bind to the complex in the plasma membrane and cannot be activated.</Comment>
    <BiopaxRef>lit_180510</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1770.0" Y="578.0" GraphId="e_138_0"/>
      <Point X="1801.0" Y="578.0" GraphId="e_138_1"/>
      <Point X="1866.0" Y="578.0" GraphId="e_138_2"/>
      <Anchor Position="0.0" GraphId="e_138_a_i"/>
      <Anchor Position="0.3229166666666667" GraphId="e_138_a_p"/>
      <Anchor Position="1.0" GraphId="e_138_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_138_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1770.0" Y="599.0" GraphId="e_138_i0_0" GraphRef="n602_REACTOME_29356" RelX="-0.047619047619047616" RelY="-1.2"/>
      <Point X="1770.0" Y="578.0" GraphId="e_138_i0_1" GraphRef="e_138_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_138_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1757.0" Y="578.0" GraphId="e_138_i1_0" GraphRef="n9_REACTOME_180269" RelX="1.044776119402985" RelY="-0.03125"/>
      <Point X="1770.0" Y="578.0" GraphId="e_138_i1_1" GraphRef="e_138_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_138_o0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1893.0" Y="578.0" GraphId="e_138_o0_0" ArrowHead="Arrow" GraphRef="n130_REACTOME_180503" RelX="-1.044776119402985" RelY="0.0"/>
      <Point X="1866.0" Y="578.0" GraphId="e_138_o0_1" GraphRef="e_138_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_138_o1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1866.0" Y="542.0" GraphId="e_138_o1_0" ArrowHead="Arrow" GraphRef="n603_REACTOME_29372" RelX="-0.01834862385321101" RelY="1.2"/>
      <Point X="1866.0" Y="578.0" GraphId="e_138_o1_1" GraphRef="e_138_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_138_c__0">
    <Graphics LineStyle="Broken" Color="000000" ConnectorType="Segmented">
      <Point X="1686.0" Y="614.0" GraphId="e_138_c__0_0" GraphRef="n9_REACTOME_180269" RelX="-0.014925373134328358" RelY="1.09375"/>
      <Point X="1686.0" Y="631.0" GraphId="e_138_c__0_1"/>
      <Point X="1801.0" Y="631.0" GraphId="e_138_c__0_2"/>
      <Point X="1801.0" Y="578.0" GraphId="e_138_c__0_3" GraphRef="e_138_a_p" ArrowHead="Line"/>
    </Graphics>
  </Line>
  <Line GraphId="e_139_REACTOME_177939">
    <Comment Source="WikiPathways-description">The kinase activity of PI3K mediates the phosphorylation of PIP2 to form PIP3</Comment>
    <BiopaxRef>lit_179899</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1817.0" Y="166.0" GraphId="e_139_0"/>
      <Point X="1730.0" Y="165.0" GraphId="e_139_1"/>
      <Point X="1648.0" Y="165.0" GraphId="e_139_2"/>
      <Anchor Position="0.0" GraphId="e_139_a_i"/>
      <Anchor Position="0.5148093985777358" GraphId="e_139_a_p"/>
      <Anchor Position="1.0" GraphId="e_139_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_139_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1890.0" Y="166.0" GraphId="e_139_i0_0" GraphRef="n3_REACTOME_179856" RelX="-1.0441176470588236" RelY="-0.045454545454545456"/>
      <Point X="1817.0" Y="166.0" GraphId="e_139_i0_1" GraphRef="e_139_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_139_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1843.0" Y="141.0" GraphId="e_139_i1_0" GraphRef="n604_REACTOME_113592" RelX="-0.717948717948718" RelY="1.2"/>
      <Point X="1817.0" Y="166.0" GraphId="e_139_i1_1" GraphRef="e_139_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_139_o0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1581.0" Y="165.0" GraphId="e_139_o0_0" ArrowHead="Arrow" GraphRef="n125_REACTOME_179838" RelX="1.0441176470588236" RelY="0.0"/>
      <Point X="1648.0" Y="165.0" GraphId="e_139_o0_1" GraphRef="e_139_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_139_o1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1614.0" Y="128.0" GraphId="e_139_o1_0" ArrowHead="Arrow" GraphRef="n605_REACTOME_29370" RelX="0.6" RelY="1.2"/>
      <Point X="1648.0" Y="165.0" GraphId="e_139_o1_1" GraphRef="e_139_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_139_c__0">
    <Graphics LineStyle="Broken" Color="000000" ConnectorType="Segmented">
      <Point X="758.0" Y="932.0" GraphId="e_139_c__0_0" GraphRef="n96_REACTOME_179791" RelX="-0.015503875968992248" RelY="1.12"/>
      <Point X="756.0" Y="993.0" GraphId="e_139_c__0_1"/>
      <Point X="2060.0" Y="994.0" GraphId="e_139_c__0_2"/>
      <Point X="2060.0" Y="220.0" GraphId="e_139_c__0_3"/>
      <Point X="1730.0" Y="220.0" GraphId="e_139_c__0_4"/>
      <Point X="1730.0" Y="165.0" GraphId="e_139_c__0_5" GraphRef="e_139_a_p" ArrowHead="Line"/>
    </Graphics>
  </Line>
  <Line GraphId="e_140_REACTOME_177940">
    <Comment Source="WikiPathways-description">GAB1 binds to EGF receptors via tyrosine autophosphorylation sites on the receptor.</Comment>
    <BiopaxRef>lit_179886</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1310.0" Y="396.0" GraphId="e_140_0"/>
      <Point X="1317.0" Y="358.0" GraphId="e_140_1"/>
      <Point X="1322.0" Y="332.0" GraphId="e_140_2" GraphRef="n106_REACTOME_180348" RelX="-0.08928571428571429" RelY="1.12" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_140_a_i"/>
      <Anchor Position="0.5933948483974907" GraphId="e_140_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_140_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="724.0" Y="302.0" GraphId="e_140_i0_0" GraphRef="n72_REACTOME_179882" RelX="1.0483870967741935" RelY="0.28125"/>
      <Point X="1310.0" Y="396.0" GraphId="e_140_i0_1" GraphRef="e_140_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_140_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="1313.0" Y="736.0" GraphId="e_140_i1_0" GraphRef="n69_REACTOME_179849" RelX="-0.02631578947368421" RelY="-1.2727272727272727"/>
      <Point X="1310.0" Y="396.0" GraphId="e_140_i1_1" GraphRef="e_140_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_144_REACTOME_212706">
    <Comment Source="WikiPathways-description">Inactive phospholipase C-gamma1 (PLC-gamma1) binds to activated epidermal growth factor receptor (EGFR).</Comment>
    <BiopaxRef>lit_212708</BiopaxRef>
    <BiopaxRef>lit_212712</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="801.0" Y="214.0" GraphId="e_144_0"/>
      <Point X="873.0" Y="214.0" GraphId="e_144_1"/>
      <Point X="930.0" Y="214.0" GraphId="e_144_2" GraphRef="n134_REACTOME_212717" RelX="-1.0393700787401574" RelY="0.0" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_144_a_i"/>
      <Anchor Position="0.5581395348837209" GraphId="e_144_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_144_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="801.0" Y="194.0" GraphId="e_144_i0_0" GraphRef="n65_REACTOME_167682" RelX="0.0" RelY="1.1666666666666667"/>
      <Point X="801.0" Y="214.0" GraphId="e_144_i0_1" GraphRef="e_144_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_144_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="724.0" Y="281.0" GraphId="e_144_i1_0" GraphRef="n72_REACTOME_179882" RelX="1.0483870967741935" RelY="-0.375"/>
      <Point X="801.0" Y="266.0" GraphId="e_144_i1_1"/>
      <Point X="801.0" Y="214.0" GraphId="e_144_i1_2" GraphRef="e_144_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_617_REACTOME_109804">
    <Comment Source="WikiPathways-description">Inactive Raf-1 is associated in the cytoplasm with 14-3-3. 14-3-3 binds to Raf-1 via the Ser259 phosphorylation site (S1). This interaction stabilises the inactive conformation of Raf-1 in which the Ras-binding Cysteine-rich domain (CRD) is obscured. The Raf-1 molecule contains an additional p21ras-binding domain (RBD), a second serine phosphorylation site at S621 (S2) and two tyrosine phosphorylation sites (at 340, Y1 and 341, Y2).</Comment>
    <BiopaxRef>lit_110028</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="252.0" Y="784.0" GraphId="e_617_0"/>
      <Point X="285.0" Y="787.0" GraphId="e_617_1"/>
      <Point X="334.0" Y="758.0" GraphId="e_617_2" GraphRef="n99_REACTOME_109787" RelX="-0.6349206349206349" RelY="1.12" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_617_a_i"/>
      <Anchor Position="0.3678735844500054" GraphId="e_617_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_617_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="226.0" Y="764.0" GraphId="e_617_i0_0" GraphRef="n117_REACTOME_48888" RelX="0.36893203883495146" RelY="1.1666666666666667"/>
      <Point X="252.0" Y="784.0" GraphId="e_617_i0_1" GraphRef="e_617_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_617_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="216.0" Y="802.0" GraphId="e_617_i1_0" GraphRef="n618_REACTOME_109786" RelX="0.3119266055045872" RelY="-1.2380952380952381"/>
      <Point X="252.0" Y="784.0" GraphId="e_617_i1_1" GraphRef="e_617_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_619_REACTOME_109802">
    <Comment Source="WikiPathways-description">14-3-3 has been displaced from Ser259. 14-3-3 may now bind its higher affinity Ser621 (S2) site. This stabilises an 'open' Raf-1 conformation that is catalytically active, and bound to p21ras via both p21ras-binding domains, CRD and RBD.</Comment>
    <BiopaxRef>lit_110028</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="160.0" Y="664.0" GraphId="e_619_0"/>
      <Point X="161.0" Y="607.0" GraphId="e_619_1"/>
      <Point X="161.0" Y="570.0" GraphId="e_619_2" GraphRef="n620_REACTOME_109789" RelX="0.0" RelY="1.3333333333333333" ArrowHead="Arrow"/>
      <Anchor Position="0.0" GraphId="e_619_a_i"/>
      <Anchor Position="0.6064197041821343" GraphId="e_619_a_p"/>
    </Graphics>
  </Line>
  <Line GraphId="e_619_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="196.0" Y="722.0" GraphId="e_619_i0_0" GraphRef="n117_REACTOME_48888" RelX="-0.21359223300970873" RelY="-1.1666666666666667"/>
      <Point X="160.0" Y="664.0" GraphId="e_619_i0_1" GraphRef="e_619_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_619_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="195.0" Y="628.0" GraphId="e_619_i1_0" GraphRef="n12_REACTOME_109788" RelX="-0.39285714285714285" RelY="1.2727272727272727"/>
      <Point X="160.0" Y="664.0" GraphId="e_619_i1_1" GraphRef="e_619_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_621_REACTOME_109829">
    <Comment Source="WikiPathways-description">An unidentified protein tyrosine kinase located in the plasma membrane phosphorylates tyrosine residues at 340 and 341 (Y1, Y2 in diagram) of Raf-1. This serves to further stabilise the active 'open' Raf-1 conformation. While the kinase has not been definitively identified, Src is a plausible candidate: coexpression of Raf-1 and Src in Sf9 cells resulted in phosphorylation of Y340/Y341 and enzymatic activationof Raf-1; Raf-1 interacts with Src and co-immunoprecipitates with Src/Fyn in NIH-3T3 cells.</Comment>
    <BiopaxRef>lit_110028</BiopaxRef>
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="91.0" Y="556.0" GraphId="e_621_0"/>
      <Point X="91.0" Y="515.0" GraphId="e_621_1"/>
      <Point X="90.0" Y="483.0" GraphId="e_621_2"/>
      <Anchor Position="0.0" GraphId="e_621_a_i"/>
      <Anchor Position="0.5615236758022348" GraphId="e_621_a_p"/>
      <Anchor Position="1.0" GraphId="e_621_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_621_i0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="91.0" Y="690.0" GraphId="e_621_i0_0" GraphRef="n622_REACTOME_113592" RelX="0.0" RelY="-1.1724137931034482"/>
      <Point X="91.0" Y="556.0" GraphId="e_621_i0_1" GraphRef="e_621_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_621_i1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="110.0" Y="556.0" GraphId="e_621_i1_0" GraphRef="n620_REACTOME_109789" RelX="-1.0515463917525774" RelY="0.0"/>
      <Point X="91.0" Y="556.0" GraphId="e_621_i1_1" GraphRef="e_621_a_i"/>
    </Graphics>
  </Line>
  <Line GraphId="e_621_o0">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="127.0" Y="466.0" GraphId="e_621_o0_0" ArrowHead="Arrow" GraphRef="n623_REACTOME_109793" RelX="-0.6530612244897959" RelY="1.2"/>
      <Point X="90.0" Y="483.0" GraphId="e_621_o0_1" GraphRef="e_621_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_621_o1">
    <Graphics LineStyle="Solid" Color="000000" ConnectorType="Segmented">
      <Point X="63.0" Y="757.0" GraphId="e_621_o1_0" ArrowHead="Arrow" GraphRef="n624_REACTOME_29370" RelX="-0.05128205128205128" RelY="-1.1724137931034482"/>
      <Point X="63.0" Y="469.0" GraphId="e_621_o1_1"/>
      <Point X="90.0" Y="483.0" GraphId="e_621_o1_2" GraphRef="e_621_a_o"/>
    </Graphics>
  </Line>
  <Line GraphId="e_621_c__0">
    <Graphics LineStyle="Broken" Color="000000" ConnectorType="Segmented">
      <Point X="141.0" Y="515.0" GraphId="e_621_c__0_0" GraphRef="n625_REACTOME_163338" RelX="-1.0413223140495869" RelY="-0.05714285714285714"/>
      <Point X="91.0" Y="515.0" GraphId="e_621_c__0_1" GraphRef="e_621_a_p" ArrowHead="Line"/>
    </Graphics>
  </Line>
  <Label GraphId="comp_text_542" GroupRef="group_comp_542" TextLabel="plasma membrane">
    <Graphics Color="000000" CenterX="97.5" CenterY="377.5" Width="129.0" Height="33.0" Valign="Middle" FontSize="12"/>
  </Label>
  <Label GraphId="comp_text_543" GroupRef="group_comp_543" TextLabel="cytosol">
    <Graphics Color="000000" CenterX="68.5" CenterY="910.5" Width="59.0" Height="33.0" Valign="Middle" FontSize="12"/>
  </Label>
  <Shape GraphId="comp_542" GroupRef="group_comp_542">
    <Graphics Color="000000" CenterX="1832.5" CenterY="365.5" Width="3617.0" Height="603.0" Valign="Middle" ShapeType="Rectangle" LineThickness="2.0"/>
  </Shape>
  <Shape GraphId="comp_543" GroupRef="group_comp_543">
    <Graphics Color="000000" CenterX="1837.0" CenterY="839.5" Width="3622.0" Height="363.0" Valign="Middle" ShapeType="Rectangle" LineThickness="2.0"/>
  </Shape>
  <InfoBox CenterX="3872.5" CenterY="6350.0"/>
  <Biopax>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_188592" rdf:id="lit_188592">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">15142631</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2004</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Review of epidermal growth factor receptor biology</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Herbst, RS</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Int J Radiat Oncol Biol Phys 59:21-6</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_188596" rdf:id="lit_188596">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10404636</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1999</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">EGF receptor</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wells, A</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Int J Biochem Cell Biol 31:637-43</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_188660" rdf:id="lit_188660">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10459005</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1999</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Employment of the epidermal growth factor receptor in growth factor-independent signaling pathways</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Carpenter, G</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Cell Biol 146:697-702</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_188661" rdf:id="lit_188661">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12297041</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2002</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ligand-induced, receptor-mediated dimerization and activation of EGF receptor</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Schlessinger, J</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell 110:669-72</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_188658" rdf:id="lit_188658">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">15550174</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2004</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The docking protein Gab1 is the primary mediator of EGF-stimulated activation of the PI-3K/Akt cell survival pathway</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mattoon, DR</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lamothe, B</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lax, I</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Schlessinger, J</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">BMC Biol 2:24</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_188610" rdf:id="lit_188610">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11498013</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2001</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Internalization of the epidermal growth factor receptor: role in signalling</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sorkin, A</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biochem Soc Trans 29:480-4</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_188605" rdf:id="lit_188605">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">8755247</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1996</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Not all Shc's roads lead to Ras</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bonfini, L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Migliaccio, E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pelicci, G</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lanfrancone, L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pelicci, PG</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Trends Biochem Sci 21:257-61</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_188597" rdf:id="lit_188597">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">14641021</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2003</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mechanisms controlling EGF receptor endocytosis and degradation</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dikic, I</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biochem Soc Trans 31:1178-81</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_182974" rdf:id="lit_182974">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">15021893</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2004</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Role of protein ubiquitylation in regulating endocytosis of receptor tyrosine kinases</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Marmor, MD</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Yarden, Y</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Oncogene 23:2057-70</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_188598" rdf:id="lit_188598">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11283727</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2001</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cbl: many adaptations to regulate protein tyrosine kinases</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Thien, CB</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Langdon, WY</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nat Rev Mol Cell Biol 2:294-307</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_188639" rdf:id="lit_188639">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11706405</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2001</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GRB2: a pivotal protein in signal transduction</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tari, AM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lopez-Berestein, G</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Semin Oncol 28:142-7</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_213067" rdf:id="lit_213067">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1501243</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1992</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Epidermal growth factor receptor: elements of intracellular communication</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">HernÃ¡ndez-Sotomayor, SM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Carpenter, G</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Membr Biol 128:81-9</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_110028" rdf:id="lit_110028">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">9069260</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1997</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The complexity of Raf-1 regulation.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Morrison, DK</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cutler, RE</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Curr Opin Cell Biol 9:174-9</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_188579" rdf:id="lit_188579">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12218189</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2002</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cbl-directed monoubiquitination of CIN85 is involved in regulation of ligand-induced degradation of EGF receptors</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Haglund, K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Shimokawa, N</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Szymkiewicz, I</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dikic, I</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Proc Natl Acad Sci U S A 99:12191-6</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_183078" rdf:id="lit_183078">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10514377</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1999</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Joazeiro, CA</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wing, SS</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Huang, H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Leverson, JD</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hunter, T</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Liu, YC</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Science 286:309-12</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_212708" rdf:id="lit_212708">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2472219</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1989</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Meisenhelder, J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Suh, PG</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rhee, SG</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hunter, T</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell 57:1109-22</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_212704" rdf:id="lit_212704">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1689311</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1990</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Identification of two epidermal growth factor-sensitive tyrosine phosphorylation sites of phospholipase C-gamma in intact HSC-1 cells</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wahl, MI</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nishibe, S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kim, JW</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kim, H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rhee, SG</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Carpenter, G</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Biol Chem 265:3944-8</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_179899" rdf:id="lit_179899">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10648629</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2000</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A novel positive feedback loop mediated by the docking protein Gab1 and phosphatidylinositol 3-kinase in epidermal growth factor receptor signaling</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rodrigues, GA</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Falasca, M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zhang, Z</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ong, SH</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Schlessinger, J</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mol Cell Biol 20:1448-59</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_183080" rdf:id="lit_183080">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">14505571</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2003</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Activated Cdc42 sequesters c-Cbl and prevents EGF receptor degradation</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wu, WJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tu, S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cerione, RA</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell 114:715-25</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_179886" rdf:id="lit_179886">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10913131</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2000</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Identification of an atypical Grb2 carboxyl-terminal SH3 domain binding site in Gab docking proteins reveals Grb2-dependent and -independent recruitment of Gab1 to receptor tyrosine kinases</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lock, LS</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Royal, I</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Naujokas, MA</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Park, M</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Biol Chem 275:31536-45</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_188664" rdf:id="lit_188664">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12766170</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2003</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Grb2-independent recruitment of Gab1 requires the C-terminal lobe and structural integrity of the Met receptor kinase domain</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lock, LS</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Frigault, MM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Saucier, C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Park, M</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Biol Chem 278:30083-90</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_183098" rdf:id="lit_183098">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11823423</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2002</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A mutant EGF-receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Waterman, H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Katz, M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rubin, C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Shtiegman, K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lavi, S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Elson, A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Jovin, T</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Yarden, Y</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">EMBO J 21:303-13</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_180308" rdf:id="lit_180308">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">8036006</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1994</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Potent SHC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Soler, C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Alvarez, CV</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Beguinot, L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Carpenter, G</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Oncogene 9:2207-15</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_180313" rdf:id="lit_180313">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">7535773</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1995</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VanderKuur, J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Allevato, G</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Billestrup, N</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Norstedt, G</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Carter-Su, C</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Biol Chem 270:7587-93</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_188642" rdf:id="lit_188642">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">8639530</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1996</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Activation of epidermal growth factor receptor by epidermal growth factor</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sherrill, JM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kyte, J</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biochemistry 35:5705-18</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_183081" rdf:id="lit_183081">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">7657591</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1995</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Galisteo, ML</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dikic, I</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Batzer, AG</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Langdon, WY</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Schlessinger, J</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Biol Chem 270:20242-5</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_183048" rdf:id="lit_183048">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">15117950</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2004</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kassenbrock, CK</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Anderson, SM</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Biol Chem 279:28017-27</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_183056" rdf:id="lit_183056">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11894095</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2002</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Soubeyran, P</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kowanetz, K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Szymkiewicz, I</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Langdon, WY</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dikic, I</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nature 416:183-7</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_180330" rdf:id="lit_180330">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">14560030</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2003</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Agazie, YM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hayman, MJ</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mol Cell Biol 23:7875-86</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_179827" rdf:id="lit_179827">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">8493579</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1993</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chardin, P</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Camonis, JH</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gale, NW</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Van Aelst, L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Schlessinger, J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wigler, MH</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bar-Sagi, D</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Science 260:1338-43</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_180518" rdf:id="lit_180518">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">15574420</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2005</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A novel role for Gab1 and SHP2 in epidermal growth factor-induced Ras activation</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Montagner, A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Yart, A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dance, M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Perret, B</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Salles, JP</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Raynal, P</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Biol Chem 280:5350-60</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_183004" rdf:id="lit_183004">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12593796</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2003</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">hSpry2 is targeted to the ubiquitin-dependent proteasome pathway by c-Cbl</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hall, AB</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Jura, N</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">DaSilva, J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Jang, YJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gong, D</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bar-Sagi, D</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Curr Biol 13:308-14</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_182989" rdf:id="lit_182989">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">16407834</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2006</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cbl escapes Cdc42-mediated inhibition by downregulation of the adaptor molecule betaPix</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Schmidt, MH</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Husnjak, K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Szymkiewicz, I</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Haglund, K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dikic, I</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Oncogene 25:3071-8</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_188628" rdf:id="lit_188628">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12234920</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2002</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wong, ES</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fong, CW</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lim, J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Yusoff, P</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Low, BC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Langdon, WY</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Guy, GR</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">EMBO J 21:4796-808</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_188630" rdf:id="lit_188630">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12593795</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2003</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sprouty fine-tunes EGF signaling through interlinked positive and negative feedback loops</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rubin, C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Litvak, V</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Medvedovsky, H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zwang, Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lev, S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Yarden, Y</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Curr Biol 13:297-307</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_183083" rdf:id="lit_183083">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">8621719</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1996</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">p120cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and Shc adaptors, and the p85 subunit of phosphatidylinositol 3-kinase</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Panchamoorthy, G</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fukazawa, T</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Miyake, S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Soltoff, S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Reedquist, K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Druker, B</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Shoelson, S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cantley, L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Band, H</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Biol Chem 271:3187-94</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_188537" rdf:id="lit_188537">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">9356464</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1997</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Grb2-associated binder-1 mediates phosphatidylinositol 3-kinase activation and the promotion of cell survival by nerve growth factor</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Holgado-Madruga, M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Moscatello, DK</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Emlet, DR</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dieterich, R</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wong, AJ</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Proc Natl Acad Sci U S A 94:12419-24</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_183032" rdf:id="lit_183032">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">15962011</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2005</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Haglund, K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Schmidt, MH</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wong, ES</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Guy, GR</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dikic, I</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">EMBO Rep 6:635-41</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_110024" rdf:id="lit_110024">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">8479541</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1993</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Li, N</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Batzer, A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Daly, R</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Yajnik, V</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Skolnik, E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Margolis, B</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Schlessinger, J</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nature 363:85-8</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_179793" rdf:id="lit_179793">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2022652</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1991</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Internalization and down-regulation of the human epidermal growth factor receptor are regulated by the carboxyl-terminal tyrosines</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Helin, K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Beguinot, L</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Biol Chem 266:8363-8</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_189933" rdf:id="lit_189933">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2543678</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1989</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">All autophosphorylation sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyl-terminal tails. Identification of a novel site in EGF receptor.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Margolis, BL</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lax, I</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kris, R</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dombalagian, M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Honegger, AM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Howk, R</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Givol, D</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ullrich, A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Schlessinger, J</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Biol Chem 264:10667-71</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_189936" rdf:id="lit_189936">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1688559</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1990</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Analysis of deletions of the carboxyl terminus of the epidermal growth factor receptor reveals self-phosphorylation at tyrosine 992 and enhanced in vivo tyrosine phosphorylation of cell substrates</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Walton, GM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chen, WS</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rosenfeld, MG</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gill, GN</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Biol Chem 265:1750-4</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_179801" rdf:id="lit_179801">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">7527043</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1994</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Grb2/Ash binds directly to tyrosines 1068 and 1086 and indirectly to tyrosine 1148 of activated human epidermal growth factor receptors in intact cells</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Okutani, T</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Okabayashi, Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kido, Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sugimoto, Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sakaguchi, K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Matuoka, K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Takenawa, T</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kasuga, M</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Biol Chem 269:31310-4</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_179887" rdf:id="lit_179887">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">7518560</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1994</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Batzer, AG</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rotin, D</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Urena, JM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Skolnik, EY</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Schlessinger, J</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mol Cell Biol 14:5192-201</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_183075" rdf:id="lit_183075">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10567358</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1999</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The epsins define a family of proteins that interact with components of the clathrin coat and contain a new protein module</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rosenthal, JA</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chen, H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Slepnev, VI</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pellegrini, L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Salcini, AE</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Di Fiore, PP</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">De Camilli, P</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Biol Chem 274:33959-65</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_183045" rdf:id="lit_183045">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">15475003</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2004</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Grovdal, LM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Stang, E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sorkin, A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Madshus, IH</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Exp Cell Res 300:388-95</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_180502" rdf:id="lit_180502">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">14665621</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2004</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ren, Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Meng, S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mei, L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zhao, ZJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Jove, R</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wu, J</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Biol Chem 279:8497-505</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_180288" rdf:id="lit_180288">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">14701753</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2004</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Distinct domains in the SHP-2 phosphatase differentially regulate epidermal growth factor receptor/NF-kappaB activation through Gab1 in glioblastoma cells</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kapoor, GS</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zhan, Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Johnson, GR</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">O'Rourke, DM</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mol Cell Biol 24:823-36</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_180316" rdf:id="lit_180316">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11323411</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2001</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phosphotyrosines 627 and 659 of Gab1 constitute a bisphosphoryl tyrosine-based activation motif (BTAM) conferring binding and activation of SHP2</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cunnick, JM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mei, L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Doupnik, CA</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wu, J</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Biol Chem 276:24380-7</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_183021" rdf:id="lit_183021">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12072436</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2002</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A ubiquitin-interacting motif (UIM) is essential for Eps15 and Eps15R ubiquitination</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Klapisz, E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sorokina, I</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lemeer, S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pijnenburg, M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Verkleij, AJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">van Bergen en Henegouwen, PM</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Biol Chem 277:30746-53</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_183040" rdf:id="lit_183040">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">15701692</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2005</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Clathrin-independent endocytosis of ubiquitinated cargos</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sigismund, S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Woelk, T</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Puri, C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Maspero, E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tacchetti, C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Transidico, P</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Di Fiore, PP</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Polo, S</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Proc Natl Acad Sci U S A 102:2760-5</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_179884" rdf:id="lit_179884">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11606067</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2001</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Unique phosphorylation mechanism of Gab1 using PI 3-kinase as an adaptor protein</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Onishi-Haraikawa, Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Funaki, M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gotoh, N</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Shibuya, M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inukai, K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Katagiri, H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fukushima, Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Anai, M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ogihara, T</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sakoda, H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ono, H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kikuchi, M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Oka, Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Asano, T</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biochem Biophys Res Commun 288:476-82</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_180339" rdf:id="lit_180339">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">9544989</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1998</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sakaguchi, K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Okabayashi, Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kido, Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kimura, S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Matsumura, Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inushima, K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kasuga, M</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mol Endocrinol 12:536-43</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_180279" rdf:id="lit_180279">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">9890893</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1999</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Identification of tyrosine phosphorylation sites in human Gab-1 protein by EGF receptor kinase in vitro</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lehr, S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kotzka, J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Herkner, A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Klein, E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Siethoff, C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Knebel, B</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Noelle, V</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bruning, JC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Klein, HW</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Meyer, HE</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Krone, W</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Muller-Wieland, D</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biochemistry 38:151-9</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_180324" rdf:id="lit_180324">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">15231819</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2004</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ligand regulates epidermal growth factor receptor kinase specificity: activation increases preference for GAB1 and SHC versus autophosphorylation sites</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fan, YX</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wong, L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Deb, TB</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Johnson, GR</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Biol Chem 279:38143-50</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_179802" rdf:id="lit_179802">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">8845374</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1995</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">In vitro phosphorylation of the epidermal growth factor receptor autophosphorylation domain by c-src: identification of phosphorylation sites and c-src SH2 domain binding sites</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lombardo, CR</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Consler, TG</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kassel, DB</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biochemistry 34:16456-66</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_180510" rdf:id="lit_180510">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10734310</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2000</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sustained recruitment of phospholipase C-gamma to Gab1 is required for HGF-induced branching tubulogenesis</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gual, P</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Giordano, S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Williams, TA</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rocchi, S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Van Obberghen, E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Comoglio, PM</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Oncogene 19:1509-18</bp:SOURCE>
    </bp:publicationXref>
    <bp:publicationXref xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" rdf:ID="lit_212712" rdf:id="lit_212712">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2153914</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pubmed</bp:DB>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1990</bp:YEAR>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tyrosine kinase activity is essential for the association of phospholipase C-gamma with the epidermal growth factor receptor</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Margolis, B</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bellot, F</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Honegger, AM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ullrich, A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Schlessinger, J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zilberstein, A</bp:AUTHORS>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mol Cell Biol 10:435-41</bp:SOURCE>
    </bp:publicationXref>
  <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#"><bp:TERM>epidermal growth factor/neuregulin signaling pathway</bp:TERM><bp:ID>PW:0000170</bp:ID><bp:Ontology>Pathway Ontology</bp:Ontology></bp:openControlledVocabulary></Biopax>
</Pathway>